Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.
Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.
One of the ESTROGEN RECEPTORS that has marked affinity for ESTRADIOL. Its expression and function differs from, and in some ways opposes, ESTROGEN RECEPTOR BETA.
One of the ESTROGEN RECEPTORS that has greater affinity for ISOFLAVONES than ESTROGEN RECEPTOR ALPHA does. There is great sequence homology with ER alpha in the DNA-binding domain but not in the ligand binding and hinge domains.
A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
2- or 4-Hydroxyestrogens. Substances that are physiologically active in mammals, especially in the control of gonadotropin secretion. Physiological activity can be ascribed to either an estrogenic action or interaction with the catecholaminergic system.
The surgical removal of one or both ovaries.
A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)
Non-steroidal compounds with estrogenic activity.
Tumors or cancer of the human BREAST.
One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.
Steroidal compounds related to ESTRADIOL, the major mammalian female sex hormone. Estradiol congeners include important estradiol precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with estrogenic activities.
An enzyme that catalyzes the desaturation (aromatization) of the ring A of C19 androgens and converts them to C18 estrogens. In this process, the 19-methyl is removed. This enzyme is membrane-bound, located in the endoplasmic reticulum of estrogen-producing cells of ovaries, placenta, testes, adipose, and brain tissues. Aromatase is encoded by the CYP19 gene, and functions in complex with NADPH-FERRIHEMOPROTEIN REDUCTASE in the cytochrome P-450 system.
Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.
A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed)
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women.
The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life.
The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
PLANT EXTRACTS and compounds, primarily ISOFLAVONES, that mimic or modulate endogenous estrogens, usually by binding to ESTROGEN RECEPTORS.
Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.
The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
Phospholipoglycoproteins produced in the fat body of egg-laying animals such as non-mammalian VERTEBRATES; ARTHROPODS; and others. Vitellogenins are secreted into the HEMOLYMPH, and taken into the OOCYTES by receptor-mediated ENDOCYTOSIS to form the major yolk proteins, VITELLINS. Vitellogenin production is under the regulation of steroid hormones, such as ESTRADIOL and JUVENILE HORMONES in insects.
A cell line derived from cultured tumor cells.
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)
An estrogen antagonist that has been used in the treatment of breast cancer.
Surgical removal or artificial destruction of gonads.
Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE.
A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.
3-Phenylchromones. Isomeric form of FLAVONOIDS in which the benzene group is attached to the 3 position of the benzopyran ring instead of the 2 position.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Nucleotide sequences, usually upstream, which are recognized by specific regulatory transcription factors, thereby causing gene response to various regulatory agents. These elements may be found in both promoter and enhancer regions.
Cytoplasmic proteins that bind estradiol, migrate to the nucleus, and regulate DNA transcription.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation.
The biosynthesis of RNA carried out on a template of DNA. The biosynthesis of DNA from an RNA template is called REVERSE TRANSCRIPTION.
Those characteristics that distinguish one SEX from the other. The primary sex characteristics are the OVARIES and TESTES and their related hormones. Secondary sex characteristics are those which are masculine or feminine but not directly related to reproduction.
Exogenous agents, synthetic and naturally occurring, which are capable of disrupting the functions of the ENDOCRINE SYSTEM including the maintenance of HOMEOSTASIS and the regulation of developmental processes. Endocrine disruptors are compounds that can mimic HORMONES, or enhance or block the binding of hormones to their receptors, or otherwise lead to activating or inhibiting the endocrine signaling pathways and hormone metabolism.
Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power.
Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.
The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.
A variation of the PCR technique in which cDNA is made from RNA via reverse transcription. The resultant cDNA is then amplified using standard PCR protocols.
Proteins, generally found in the CYTOPLASM, that specifically bind ANDROGENS and mediate their cellular actions. The complex of the androgen and receptor migrates to the CELL NUCLEUS where it induces transcription of specific segments of DNA.
The relationship between the dose of an administered drug and the response of the organism to the drug.
Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely.
The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.
In humans, one of the paired regions in the anterior portion of the THORAX. The breasts consist of the MAMMARY GLANDS, the SKIN, the MUSCLES, the ADIPOSE TISSUE, and the CONNECTIVE TISSUES.
The period of cyclic physiological and behavior changes in non-primate female mammals that exhibit ESTRUS. The estrous cycle generally consists of 4 or 5 distinct periods corresponding to the endocrine status (PROESTRUS; ESTRUS; METESTRUS; DIESTRUS; and ANESTRUS).
Therapeutic use of hormones to alleviate the effects of hormone deficiency.
Ducts that serve exclusively for the passage of eggs from the ovaries to the exterior of the body. In non-mammals, they are termed oviducts. In mammals, they are highly specialized and known as FALLOPIAN TUBES.
The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.
An estrogenic steroid produced by HORSES. It has a total of five double bonds in the A- and B-ring. High concentration of equilenin is found in the URINE of pregnant mares.
Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
All of the processes involved in increasing CELL NUMBER including CELL DIVISION.
A potent androgenic metabolite of TESTOSTERONE. It is produced by the action of the enzyme 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE.
DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes.
A synthetic estrogen that has been used as a hormonal antineoplastic agent.
Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.
(6 alpha)-17-Hydroxy-6-methylpregn-4-ene-3,20-dione. A synthetic progestational hormone used in veterinary practice as an estrus regulator.
Processes that stimulate the GENETIC TRANSCRIPTION of a gene or set of genes.
Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.
Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.
Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
Material prepared from plants.
The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION.
Enzymes that catalyze the oxidation of estradiol at the 17-hydroxyl group in the presence of NAD+ or NADP+ to yield estrone and NADH or NADPH. The 17-hydroxyl group can be in the alpha- or beta-configuration. EC 1.1.1.62
An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.)
Elements of limited time intervals, contributing to particular results or situations.
A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed)
A class of enzymes that catalyzes the oxidation of 17-hydroxysteroids to 17-ketosteroids. EC 1.1.-.
The measurement of an organ in volume, mass, or heaviness.
A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.
The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION.
MAMMARY GLANDS in the non-human MAMMALS.
The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES.
Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed)
Steroidal compounds related to PROGESTERONE, the major mammalian progestational hormone. Progesterone congeners include important progesterone precursors in the biosynthetic pathways, metabolites, derivatives, and synthetic steroids with progestational activities.
An isoflavonoid derived from soy products. It inhibits PROTEIN-TYROSINE KINASE and topoisomerase-II (DNA TOPOISOMERASES, TYPE II); activity and is used as an antineoplastic and antitumor agent. Experimentally, it has been shown to induce G2 PHASE arrest in human and murine cell lines and inhibits PROTEIN-TYROSINE KINASE.
The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence.
Triazoles are a class of antifungal drugs that contain a triazole ring in their chemical structure and work by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting the integrity and function of the membrane.
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
The surgical removal of one or both testicles.
A pharmaceutical preparation containing a mixture of esterified estrogens derived from estrogen sulfates, principally from ESTRONE sulfate. Esterified estrogen content should be 75-85% of the estrone sulfate and 6-15% of the EQUILIN sulfate.
A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity.
The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments.
A nuclear receptor coactivator with specificity for ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and THYROID HORMONE RECEPTORS. It contains a histone acetyltransferase activity that may play a role in the transcriptional activation of chromatin regions.
Enzymes which transfer sulfate groups to various acceptor molecules. They are involved in posttranslational sulfation of proteins and sulfate conjugation of exogenous chemicals and bile acids. EC 2.8.2.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
A daidzein derivative occurring naturally in forage crops which has some estrogenic activity.
The simultaneous or sequential binding of multiple cell surface receptors to different ligands resulting in coordinated stimulation or suppression of signal transduction.
Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories.
An estrogenic steroid produced by HORSES. It has a total of four double bonds in the A- and B-ring. High concentration of euilin is found in the URINE of pregnant mares.
A nuclear receptor coactivator with specificity for ESTROGEN RECEPTORS and PROGESTERONE RECEPTORS. It contains a histone acetyltransferase activity that may play a role in CHROMATIN REMODELING during the process of nuclear receptor-induced transcription. The coactivator has been found at elevated levels in certain HORMONE-DEPENDENT NEOPLASMS such as those found in BREAST CANCER.
Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process.
Development of female secondary SEX CHARACTERISTICS in the MALE. It is due to the effects of estrogenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.
A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.
A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit OVULATION.
The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS.
An arylsulfatase with high specificity towards sulfated steroids. Defects in this enzyme are the cause of ICHTHYOSIS, X-LINKED.
A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM.
Enzyme that catalyzes the movement of a methyl group from S-adenosylmethionone to a catechol or a catecholamine.
Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components.
A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
A synthetic progestin which is useful for the study of progestin distribution and progestin tissue receptors, as it is not bound by transcortin and binds to progesterone receptors with a higher association constant than progesterone.
A transcription factor that partners with ligand bound GLUCOCORTICOID RECEPTORS and ESTROGEN RECEPTORS to stimulate GENETIC TRANSCRIPTION. It plays an important role in FERTILITY as well as in METABOLISM of LIPIDS.
The determination of the pattern of genes expressed at the level of GENETIC TRANSCRIPTION, under specific circumstances or in a specific cell.
A group of polycyclic compounds closely related biochemically to TERPENES. They include cholesterol, numerous hormones, precursors of certain vitamins, bile acids, alcohols (STEROLS), and certain natural drugs and poisons. Steroids have a common nucleus, a fused, reduced 17-carbon atom ring system, cyclopentanoperhydrophenanthrene. Most steroids also have two methyl groups and an aliphatic side-chain attached to the nucleus. (From Hawley's Condensed Chemical Dictionary, 11th ed)
Region of hypothalamus between the ANTERIOR COMMISSURE and OPTIC CHIASM.
A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed)
Tumors or cancer of the UTERUS.
Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.
The parts of a macromolecule that directly participate in its specific combination with another molecule.
A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins.
A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principle cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX.
A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine).
The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)
The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS.
Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE.
The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.
Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids.
A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Sex hormone-binding protein has the same amino acid sequence as ANDROGEN-BINDING PROTEIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure.
The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
The application of suitable drug dosage forms to the skin for either local or systemic effects.
Genes whose expression is easily detectable and therefore used to study promoter activity at many positions in a target genome. In recombinant DNA technology, these genes may be attached to a promoter region of interest.
Amides composed of unsaturated aliphatic FATTY ACIDS linked with AMINES by an amide bond. They are most prominent in ASTERACEAE; PIPERACEAE; and RUTACEAE; and also found in ARISTOLOCHIACEAE; BRASSICACEAE; CONVOLVULACEAE; EUPHORBIACEAE; MENISPERMACEAE; POACEAE; and SOLANACEAE. They are recognized by their pungent taste and for causing numbing and salivation.
Achievement of full sexual capacity in animals and in humans.
Cells that line the inner and outer surfaces of the body by forming cellular layers (EPITHELIUM) or masses. Epithelial cells lining the SKIN; the MOUTH; the NOSE; and the ANAL CANAL derive from ectoderm; those lining the RESPIRATORY SYSTEM and the DIGESTIVE SYSTEM derive from endoderm; others (CARDIOVASCULAR SYSTEM and LYMPHATIC SYSTEM) derive from mesoderm. Epithelial cells can be classified mainly by cell shape and function into squamous, glandular and transitional epithelial cells.
Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures.
One of the mechanisms by which CELL DEATH occurs (compare with NECROSIS and AUTOPHAGOCYTOSIS). Apoptosis is the mechanism responsible for the physiological deletion of cells and appears to be intrinsically programmed. It is characterized by distinctive morphologic changes in the nucleus and cytoplasm, chromatin cleavage at regularly spaced sites, and the endonucleolytic cleavage of genomic DNA; (DNA FRAGMENTATION); at internucleosomal sites. This mode of cell death serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth.
Oral contraceptives which owe their effectiveness to hormonal preparations.
The smooth muscle coat of the uterus, which forms the main mass of the organ.
The rate dynamics in chemical or physical systems.
The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety.

Plasma concentration changes in LH and FSH following electrochemical stimulation of the medial preoptic are or dorsal anterior hypothalamic area of estrogen- or androgen-sterilized rats.(1/6438)

 (+info)

Possible suppression of host resistance by estrogen therapy for prostatic cancer.(2/6438)

 (+info)

The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. (3/6438)

We have established or characterized six lines of human breast cancer maintained in long-term tissue culture for at least 1 year and have examined these lines for estrogen responsiveness. One of these cell lines, MCF-7, shows marked stimulation of macromolecular synthesis and cell division with physiological concentrations of estradiol. Antiestrogens are strongly inhibitory, and at concentrations greater than 3 X 10(-7) M they kill cells. Antiestrogen effects are prevented by simultaneous treatment with estradiol or reversed by addition of estradiol to cells incubated in antiestrogen. Responsive cell lines contain high-affinity specific estradiol receptors. Antiestrogens compete with estradiol for these receptors but have a lower apparent affinity for the receptor than estrogens. Stimulation of cells by estrogens is biphasic, with inhibition and cell death at concentrations of 17beta-estradiol or diethylstilbestrol exceeding 10(-7) M. Killing by high concentrations of estrogen is probably a nonspecific effect in that we observe this response with 17alpha-estradiol at equivalent concentrations and in the otherwise unresponsive cells that contain no estrogen receptor sites.  (+info)

Marker molecules of human endometrial differentiation can be hormonally regulated under in-vitro conditions as in-vivo. (4/6438)

An established cell culture system of isolated human endometrial stromal and epithelial cells has been used to study the effects of oestrogen and progesterone, as well as their antagonists, upon endometrial cells. Normal hormonal regulation in vivo was investigated simultaneously in endometrial tissue samples taken at different phases of the menstrual cycle. Several marker molecules analysed by immunohistochemistry appeared to depend strongly on endocrine regulation and could be traced in culture. Immunohistochemically, basic parameters of cell biology were identified in vitro, e.g. cell proliferation (Ki-67), adhesion molecules (beta3 integrin) and paracrine factors (leukaemia inhibitory factor). The most reliable parameters to assess hormonal influences were oestrogen and progesterone receptor molecules. Immunohistochemical localization could be improved by molecular biological analysis using RT-PCR. In the presence of oestrogen, a significant expression of hormone receptors was also shown by RT-PCR, and withdrawal of oestrogens and addition of gestagen, i.e. medroxyprogesterone acetate, caused receptor downregulation. Addition of the anti-oestrogen ICI 182.780 to cell-culture medium significantly decreased the synthesis of progesterone receptors.  (+info)

Modulation of oestrogenic effects by progesterone antagonists in the rat uterus. (5/6438)

Antiprogestins can modulate oestrogenic effects in various oestrogen-dependent tissues, dependent on species, tissue, dose and duration of treatment. Enhanced oestrogenic responses to mifepristone and onapristone occur in vitro and in vivo. However, the antiprogestins mifepristone, onapristone, and ZK 137 316 can block the ability of oestradiol to increase endometrial growth in non-human primates. Our purposes were firstly, to decide whether mifepristone and onapristone had direct oestrogenic activity in vitro and in the uterus of spayed and immature rats, and secondly, to discover whether antiprogestins exhibit inhibitory effects on oestrogen action in the uterus in spayed, oestrogen-substituted rats. In transactivation assays, mifepristone induced oestrogenic response, whereas onapristone had only marginal effects on reporter gene transcription. In immature rats, onapristone and mifepristone markedly increased uterine weights, and onapristone, but not mifepristone significantly enhanced endometrial luminal epithelial height, a sensitive oestrogen parameter. Conversely, in spayed and adrenalectomized rats, neither onapristone nor mifepristone changed uterine weights or endometrial morphology, indicating that their effects in immature rats were indirect. In spayed, oestrogen-substituted rats, antiprogestins did not block oestradiol-stimulated endometrial growth and luminal and glandular epithelium were stimulated more after antiprogestin plus oestrogen, than after oestradiol alone. All compounds induced compaction of the uterine stroma. In spayed rats, onapristone and some other 13alpha-configured (type 1) antagonists (ZK 135 569, ZK 131 535) reduced oestradiol-stimulated myometrial proliferation and induced an overall uterine weight reduction in animals treated with oestrogen and antiprogestins, in comparison with oestradiol-treated controls. 13beta- configured (type II) antagonists, including mifepristone, lilopristone and ZK 112 993, were not effective. In the uteri of spayed rats, onapristone was also found to enhance the oestradiol-stimulatory effect on expression of the oestrogen-dependent proto-oncogene, c-fos. In conclusion, antiprogestins do not inhibit, but rather enhance, oestrogen-induced uterine glandular and luminal epithelium in spayed rats, contrary to their effects in primates. The rat model is unsuitable to study endometrial antiproliferative effects of antiprogestins in primate uteri.  (+info)

Endometriosis: a dysfunction and disease of the archimetra. (6/6438)

Endometriosis is considered primarily a disease of the endometrial-subendometrial unit or archimetra. The clinical picture of endometriosis characterises this disease as a hyperactivation of genuine archimetrial functions such as proliferation, inflammatory defence and peristalsis. While the aetiology of the disease remains to be elucidated, a key event appears to consist in the local production of extraovarian oestrogen by a pathological expression of the P450 aromatase. The starting event may consist in a hyperactivity of the endometrial inflammatory defence, a hyperactivity of the endometrial oxytocin/oxytocin receptor system or in the pathological expression of the P450 aromatase system itself. Regardless of which of these levels the starting event is localized in, they influence each other on both the level of the archimetra and the endometriotic lesions. Locally elevated oestrogen levels inevitably up-regulate the endometrial oxytocin mRNA and increased levels of oxytocin result in uterine hyperperistalsis, increased transtubal seeding of endometrial tissue fragments and finally subfertility and infertility by impairment of the uterine mechanism of rapid and sustained sperm transport. Locally increased levels of oestrogen lead, on both the level of the endometrial-subendometrial unit and the endometriotic lesion, to processes of hyperproliferation. These processes result, on the level of the uterus, in an infiltrative growth of elements of the archimetra into the neometra and, on the level of the endometriotic lesion, in infiltrative endometriosis. There is circumstantial evidence that trauma might be an important initial event that induces the specific biochemical and cellular responses of the archimetra. This model is able to explain both the pleiomorphic appearance of endometriosis and the, up until now, enigmatic infertility associated with mild and moderate endometriosis.  (+info)

Relationship between metabolism of androstenone and skatole in intact male pigs. (7/6438)

The relationship between the metabolism of androsterone and skatole, the major compounds responsible for boar taint, was investigated in F4 Swedish Yorkshire x European Wild Pig intact males. The metabolism of androstenone and skatole were studied in liver microsomes, and the testicular steroid production was measured in testes microsomes. Including androstenone in the assays of skatole metabolism reduced the formation of 6-hydroxyskatole (pro-MII), and three other skatole metabolites (P<.05). The formation of three additional metabolites was not affected. Liver microsomal incubations of androstenone produced two metabolites, I and II. The rate of the formation of metabolite I and the rate of androstenone metabolism were correlated with the rate of skatole metabolism. Liver metabolism of androstenone was not related to levels of androstenone in fat. Testicular synthesis of 16-androstene steroids was correlated with combined synthesis of estrogens and androgens, plasma levels of androstenone, levels of skatole in fat, and skatole metabolism in the liver (P<.05). Plasma levels of estrone sulfate were correlated with levels of skatole in fat and with androstenone levels in fat and plasma and were negatively correlated with synthesis of skatole metabolite F-1 and pro-MII sulfation. These results indicate that the liver metabolism of androstenone and skatole are related. However, it is likely that the relationship between levels of androstenone and skatole in fat is due more to a link between the testicular synthesis of androstenone rather than to the metabolism of androstenone and skatole in the liver. Sex steroids may affect this relationship because of their biosynthesis along with androstenone and possible inhibition of skatole metabolism in the liver.  (+info)

Estrogen induction of VLDLy assembly in egg-laying hens. (8/6438)

The yolk of a 60-g chicken egg contains 6 g of triacylglycerols transported to the oocyte from the liver of the laying hen in apolipoprotein (apo) B-containing particles. With the onset of egg production, estrogen shifts hepatocytic lipoprotein production from generic VLDL to VLDLy (yolk targeted). These VLDLy are triacylglycerol-rich particles; they are reduced in size by one half, are resistant to lipoprotein lipase and are taken up intact by oocyte receptors. The VLDLy pathway for apoB provides sufficient energy for the caloric requirements of chick development. VLDLy size reduction occurs in spite of surplus liver triacylglycerols and is necessary for VLDL particles to pass through the granulosa basal lamina and reach the receptors located on the oocyte surface. New ultrastructural data show that some proximal tubule cells of bird kidney secrete generic VLDL, perhaps providing energy and other VLDL-associated nutrients to tissues bypassed by VLDLy. Birds are an apoB100-only species, providing a natural in vivo model with which to investigate mechanisms of apoB100 VLDL assembly. Preliminary studies of liver lipoprotein assembly intermediates isolated from the biosynthetic membranes (endoplasmic reticulum) of the laying hen are consistent with the presence of both putative first- and second-step precursor particles of VLDLy. These findings suggest that the two-step mechanism of apoB core lipidation is an ancient development in apoB biology, handed down to mammals from oviparous ancestors.  (+info)

Estrogens are a group of steroid hormones that are primarily responsible for the development and regulation of female sexual characteristics and reproductive functions. They are also present in lower levels in males. The main estrogen hormone is estradiol, which plays a key role in promoting the growth and development of the female reproductive system, including the uterus, fallopian tubes, and breasts. Estrogens also help regulate the menstrual cycle, maintain bone density, and have important effects on the cardiovascular system, skin, hair, and cognitive function.

Estrogens are produced primarily by the ovaries in women, but they can also be produced in smaller amounts by the adrenal glands and fat cells. In men, estrogens are produced from the conversion of testosterone, the primary male sex hormone, through a process called aromatization.

Estrogen levels vary throughout a woman's life, with higher levels during reproductive years and lower levels after menopause. Estrogen therapy is sometimes used to treat symptoms of menopause, such as hot flashes and vaginal dryness, or to prevent osteoporosis in postmenopausal women. However, estrogen therapy also carries risks, including an increased risk of certain cancers, blood clots, and stroke, so it is typically recommended only for women who have a high risk of these conditions.

Estrogen receptors (ERs) are a type of nuclear receptor protein that are expressed in various tissues and cells throughout the body. They play a critical role in the regulation of gene expression and cellular responses to the hormone estrogen. There are two main subtypes of ERs, ERα and ERβ, which have distinct molecular structures, expression patterns, and functions.

ERs function as transcription factors that bind to specific DNA sequences called estrogen response elements (EREs) in the promoter regions of target genes. When estrogen binds to the ER, it causes a conformational change in the receptor that allows it to recruit co-activator proteins and initiate transcription of the target gene. This process can lead to a variety of cellular responses, including changes in cell growth, differentiation, and metabolism.

Estrogen receptors are involved in a wide range of physiological processes, including the development and maintenance of female reproductive tissues, bone homeostasis, cardiovascular function, and cognitive function. They have also been implicated in various pathological conditions, such as breast cancer, endometrial cancer, and osteoporosis. As a result, ERs are an important target for therapeutic interventions in these diseases.

Estrogen Receptor alpha (ERα) is a type of nuclear receptor protein that is activated by the hormone estrogen. It is encoded by the gene ESR1 and is primarily expressed in the cells of the reproductive system, breast, bone, liver, heart, and brain tissue.

When estrogen binds to ERα, it causes a conformational change in the receptor, which allows it to dimerize and translocate to the nucleus. Once in the nucleus, ERα functions as a transcription factor, binding to specific DNA sequences called estrogen response elements (EREs) and regulating the expression of target genes.

ERα plays important roles in various physiological processes, including the development and maintenance of female reproductive organs, bone homeostasis, and lipid metabolism. It is also a critical factor in the growth and progression of certain types of breast cancer, making ERα status an important consideration in the diagnosis and treatment of this disease.

Estrogen Receptor beta (ER-β) is a protein that is encoded by the gene ESR2 in humans. It belongs to the family of nuclear receptors, which are transcription factors that regulate gene expression in response to hormonal signals. ER-β is one of two main estrogen receptors, the other being Estrogen Receptor alpha (ER-α), and it plays an important role in mediating the effects of estrogens in various tissues, including the breast, uterus, bone, brain, and cardiovascular system.

Estrogens are steroid hormones that play a critical role in the development and maintenance of female reproductive and sexual function. They also have important functions in other tissues, such as maintaining bone density and promoting cognitive function. ER-β is widely expressed in many tissues, including those outside of the reproductive system, suggesting that it may have diverse physiological roles beyond estrogen-mediated reproduction.

ER-β has been shown to have both overlapping and distinct functions from ER-α, and its expression patterns differ between tissues. For example, in the breast, ER-β is expressed at higher levels in normal tissue compared to cancerous tissue, suggesting that it may play a protective role against breast cancer development. In contrast, in the uterus, ER-β has been shown to have anti-proliferative effects and may protect against endometrial cancer.

Overall, ER-β is an important mediator of estrogen signaling and has diverse physiological roles in various tissues. Understanding its functions and regulation may provide insights into the development of novel therapies for a range of diseases, including cancer, osteoporosis, and cardiovascular disease.

Estradiol is a type of estrogen, which is a female sex hormone. It is the most potent and dominant form of estrogen in humans. Estradiol plays a crucial role in the development and maintenance of secondary sexual characteristics in women, such as breast development and regulation of the menstrual cycle. It also helps maintain bone density, protect the lining of the uterus, and is involved in cognition and mood regulation.

Estradiol is produced primarily by the ovaries, but it can also be synthesized in smaller amounts by the adrenal glands and fat cells. In men, estradiol is produced from testosterone through a process called aromatization. Abnormal levels of estradiol can contribute to various health issues, such as hormonal imbalances, infertility, osteoporosis, and certain types of cancer.

I'm sorry for any confusion, but "Estrogens, Catechol" is not a recognized medical term or classification. Estrogens are a group of steroid hormones that are primarily responsible for the development and maintenance of female sexual characteristics. They are produced mainly in the ovaries, but also in other tissues such as fat, liver, and breast tissue.

Catechols, on the other hand, are a type of chemical compound that contain a benzene ring with two hydroxyl groups attached to it in a particular arrangement. Some estrogens can be metabolized into catechol estrogen metabolites, which have been studied for their potential role in cancer development and progression.

If you have any specific questions about estrogens or catechols, I'd be happy to try to help answer them!

Ovariectomy is a surgical procedure in which one or both ovaries are removed. It is also known as "ovary removal" or "oophorectomy." This procedure is often performed as a treatment for various medical conditions, including ovarian cancer, endometriosis, uterine fibroids, and pelvic pain. Ovariectomy can also be part of a larger surgical procedure called an hysterectomy, in which the uterus is also removed.

In some cases, an ovariectomy may be performed as a preventative measure for individuals at high risk of developing ovarian cancer. This is known as a prophylactic ovariectomy. After an ovariectomy, a person will no longer have menstrual periods and will be unable to become pregnant naturally. Hormone replacement therapy may be recommended in some cases to help manage symptoms associated with the loss of hormones produced by the ovaries.

Selective estrogen receptor modulators (SERMs) are a class of medications that act as either agonists or antagonists on the estrogen receptors in different tissues of the body. They selectively bind to estrogen receptors and can have opposite effects depending on the target tissue. In some tissues, such as bone and liver, SERMs behave like estrogens and stimulate estrogen receptors, promoting bone formation and reducing cholesterol levels. In contrast, in other tissues, such as breast and uterus, SERMs block the effects of estrogen, acting as estrogen antagonists and preventing the growth of hormone-sensitive tumors.

Examples of SERMs include:

* Tamoxifen: used for the prevention and treatment of breast cancer in both pre- and postmenopausal women.
* Raloxifene: used for the prevention and treatment of osteoporosis in postmenopausal women, as well as for reducing the risk of invasive breast cancer in high-risk postmenopausal women.
* Toremifene: used for the treatment of metastatic breast cancer in postmenopausal women with estrogen receptor-positive tumors.
* Lasofoxifene: used for the prevention and treatment of osteoporosis in postmenopausal women, as well as reducing the risk of invasive breast cancer in high-risk postmenopausal women.

It is important to note that SERMs can have side effects, including hot flashes, vaginal dryness, and an increased risk of blood clots. The choice of a specific SERM depends on the individual patient's needs, medical history, and potential risks.

Non-steroidal estrogens are a class of compounds that exhibit estrogenic activity but do not have a steroid chemical structure. They are often used in hormone replacement therapy and to treat symptoms associated with menopause. Examples of non-steroidal estrogens include:

1. Phytoestrogens: These are plant-derived compounds that have estrogenic activity. They can be found in various foods such as soy, nuts, seeds, and some fruits and vegetables.
2. Selective Estrogen Receptor Modulators (SERMs): These are synthetic compounds that act as estrogen receptor agonists or antagonists, depending on the target tissue. Examples include tamoxifen, raloxifene, and toremifene. They are used in the treatment of breast cancer and osteoporosis.
3. Designer Estrogens: These are synthetic compounds that have been specifically designed to mimic the effects of estrogen. They are often used in research but have not been approved for clinical use.

It is important to note that non-steroidal estrogens can also have side effects and risks, including an increased risk of certain types of cancer, cardiovascular disease, and thromboembolic events. Therefore, their use should be carefully monitored and managed by a healthcare professional.

Breast neoplasms refer to abnormal growths in the breast tissue that can be benign or malignant. Benign breast neoplasms are non-cancerous tumors or growths, while malignant breast neoplasms are cancerous tumors that can invade surrounding tissues and spread to other parts of the body.

Breast neoplasms can arise from different types of cells in the breast, including milk ducts, milk sacs (lobules), or connective tissue. The most common type of breast cancer is ductal carcinoma, which starts in the milk ducts and can spread to other parts of the breast and nearby structures.

Breast neoplasms are usually detected through screening methods such as mammography, ultrasound, or MRI, or through self-examination or clinical examination. Treatment options for breast neoplasms depend on several factors, including the type and stage of the tumor, the patient's age and overall health, and personal preferences. Treatment may include surgery, radiation therapy, chemotherapy, hormone therapy, or targeted therapy.

Tamoxifen is a selective estrogen receptor modulator (SERM) medication that is primarily used in the treatment and prevention of breast cancer. It works by blocking the action of estrogen in the body, particularly in breast tissue. This can help to stop or slow the growth of hormone-sensitive tumors.

Tamoxifen has been approved by the U.S. Food and Drug Administration (FDA) for use in both men and women. It is often used as a part of adjuvant therapy, which is treatment given after surgery to reduce the risk of cancer recurrence. Tamoxifen may also be used to treat metastatic breast cancer that has spread to other parts of the body.

Common side effects of tamoxifen include hot flashes, vaginal discharge, and changes in mood or vision. Less commonly, tamoxifen can increase the risk of blood clots, stroke, and endometrial cancer (cancer of the lining of the uterus). However, for many women with breast cancer, the benefits of taking tamoxifen outweigh the risks.

It's important to note that while tamoxifen can be an effective treatment option for some types of breast cancer, it is not appropriate for all patients. A healthcare professional will consider a variety of factors when determining whether tamoxifen is the right choice for an individual patient.

Estradiol congeners refer to chemical compounds that are structurally similar to estradiol, which is the most potent and prevalent form of estrogen in humans. Estradiol congeners can be naturally occurring or synthetic and may have similar or different biological activities compared to estradiol.

These compounds can be found in various sources, including plants, animals, and industrial products. Some estradiol congeners are used in pharmaceuticals as hormone replacement therapies, while others are considered environmental pollutants and may have endocrine-disrupting effects on wildlife and humans.

Examples of estradiol congeners include:

1. Estrone (E1): a weak estrogen that is produced in the body from estradiol and is also found in some plants.
2. Estriol (E3): a weaker estrogen that is produced in large quantities during pregnancy.
3. Diethylstilbestrol (DES): a synthetic estrogen that was prescribed to pregnant women from the 1940s to the 1970s to prevent miscarriage, but was later found to have serious health effects on their offspring.
4. Zeranol: a synthetic non-steroidal estrogen used as a growth promoter in livestock.
5. Bisphenol A (BPA): a chemical used in the production of plastics and epoxy resins, which has been shown to have weak estrogenic activity and may disrupt the endocrine system.

Aromatase is a enzyme that belongs to the cytochrome P450 superfamily, and it is responsible for converting androgens into estrogens through a process called aromatization. This enzyme plays a crucial role in the steroid hormone biosynthesis pathway, particularly in females where it is primarily expressed in adipose tissue, ovaries, brain, and breast tissue.

Aromatase inhibitors are used as a treatment for estrogen receptor-positive breast cancer in postmenopausal women, as they work by blocking the activity of aromatase and reducing the levels of circulating estrogens in the body.

Progesterone receptors (PRs) are a type of nuclear receptor proteins that are expressed in the nucleus of certain cells and play a crucial role in the regulation of various physiological processes, including the menstrual cycle, embryo implantation, and maintenance of pregnancy. These receptors bind to the steroid hormone progesterone, which is produced primarily in the ovaries during the second half of the menstrual cycle and during pregnancy.

Once progesterone binds to the PRs, it triggers a series of molecular events that lead to changes in gene expression, ultimately resulting in the modulation of various cellular functions. Progesterone receptors exist in two main isoforms, PR-A and PR-B, which differ in their size, structure, and transcriptional activity. Both isoforms are expressed in a variety of tissues, including the female reproductive tract, breast, brain, and bone.

Abnormalities in progesterone receptor expression or function have been implicated in several pathological conditions, such as uterine fibroids, endometriosis, breast cancer, and osteoporosis. Therefore, understanding the molecular mechanisms underlying PR signaling is essential for developing novel therapeutic strategies to treat these disorders.

Diethylstilbestrol (DES) is a synthetic form of the hormone estrogen that was prescribed to pregnant women from the 1940s until the early 1970s to prevent miscarriage, premature labor, and other complications of pregnancy. However, it was later discovered that DES could cause serious health problems in both the mothers who took it and their offspring.

DES is a non-selective estrogen agonist, meaning that it binds to and activates both estrogen receptors (ERα and ERβ) in the body. It has a higher binding affinity for ERα than for ERβ, which can lead to disruptions in normal hormonal signaling pathways.

In addition to its use as a pregnancy aid, DES has also been used in the treatment of prostate cancer, breast cancer, and other conditions associated with hormonal imbalances. However, due to its potential health risks, including an increased risk of certain cancers, DES is no longer widely used in clinical practice.

Some of the known health effects of DES exposure include:

* In women who were exposed to DES in utero (i.e., their mothers took DES during pregnancy):
+ A rare form of vaginal or cervical cancer called clear cell adenocarcinoma
+ Abnormalities of the reproductive system, such as structural changes in the cervix and vagina, and an increased risk of infertility, ectopic pregnancy, and preterm delivery
+ An increased risk of breast cancer later in life
* In men who were exposed to DES in utero:
+ Undescended testicles
+ Abnormalities of the penis and scrotum
+ A higher risk of testicular cancer
* In both men and women who were exposed to DES in utero or who took DES themselves:
+ An increased risk of certain types of breast cancer
+ A possible increased risk of cardiovascular disease, including high blood pressure and stroke.

It is important for individuals who have been exposed to DES to inform their healthcare providers of this fact, as it may have implications for their medical care and monitoring.

The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.

The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.

Estrone is a type of estrogen, which is a female sex hormone. It's one of the three major naturally occurring estrogens in women, along with estradiol and estriol. Estrone is weaker than estradiol but has a longer half-life, meaning it remains active in the body for a longer period of time.

Estrone is produced primarily in the ovaries, adrenal glands, and fat tissue. In postmenopausal women, when the ovaries stop producing estradiol, estrone becomes the dominant form of estrogen. It plays a role in maintaining bone density, regulating the menstrual cycle, and supporting the development and maintenance of female sexual characteristics.

Like other forms of estrogen, estrone can also have effects on various tissues throughout the body, including the brain, heart, and breast tissue. Abnormal levels of estrone, either too high or too low, can contribute to a variety of health issues, such as osteoporosis, menstrual irregularities, and increased risk of certain types of cancer.

Postmenopause is a stage in a woman's life that follows 12 months after her last menstrual period (menopause) has occurred. During this stage, the ovaries no longer release eggs and produce lower levels of estrogen and progesterone hormones. The reduced levels of these hormones can lead to various physical changes and symptoms, such as hot flashes, vaginal dryness, and mood changes. Postmenopause is also associated with an increased risk of certain health conditions, including osteoporosis and heart disease. It's important for women in postmenopause to maintain a healthy lifestyle, including regular exercise, a balanced diet, and routine medical check-ups to monitor their overall health and manage any potential risks.

Progesterone is a steroid hormone that is primarily produced in the ovaries during the menstrual cycle and in pregnancy. It plays an essential role in preparing the uterus for implantation of a fertilized egg and maintaining the early stages of pregnancy. Progesterone works to thicken the lining of the uterus, creating a nurturing environment for the developing embryo.

During the menstrual cycle, progesterone is produced by the corpus luteum, a temporary structure formed in the ovary after an egg has been released from a follicle during ovulation. If pregnancy does not occur, the levels of progesterone will decrease, leading to the shedding of the uterine lining and menstruation.

In addition to its reproductive functions, progesterone also has various other effects on the body, such as helping to regulate the immune system, supporting bone health, and potentially influencing mood and cognition. Progesterone can be administered medically in the form of oral pills, intramuscular injections, or vaginal suppositories for various purposes, including hormone replacement therapy, contraception, and managing certain gynecological conditions.

Ethinyl estradiol is a synthetic form of the hormone estrogen that is often used in various forms of hormonal contraception, such as birth control pills. It works by preventing ovulation and thickening cervical mucus to make it more difficult for sperm to reach the egg. Ethinyl estradiol may also be used in combination with other hormones to treat menopausal symptoms or hormonal disorders.

It is important to note that while ethinyl estradiol can be an effective form of hormonal therapy, it can also carry risks and side effects, such as an increased risk of blood clots, stroke, and breast cancer. As with any medication, it should only be used under the guidance and supervision of a healthcare provider.

Progestins are a class of steroid hormones that are similar to progesterone, a natural hormone produced by the ovaries during the menstrual cycle and pregnancy. They are often used in hormonal contraceptives, such as birth control pills, shots, and implants, to prevent ovulation and thicken the cervical mucus, making it more difficult for sperm to reach the egg. Progestins are also used in menopausal hormone therapy to alleviate symptoms of menopause, such as hot flashes and vaginal dryness. Additionally, progestins may be used to treat endometriosis, uterine fibroids, and breast cancer. Different types of progestins have varying properties and may be more suitable for certain indications or have different side effect profiles.

Phytoestrogens are compounds found in plants that have estrogen-like properties. They can bind to and activate or inhibit the action of estrogen receptors in the body, depending on their structure and concentration. Phytoestrogens are present in a variety of foods, including soy products, nuts, seeds, fruits, and vegetables.

Phytoestrogens have been studied for their potential health benefits, such as reducing the risk of hormone-dependent cancers (e.g., breast cancer), improving menopausal symptoms, and promoting bone health. However, their effects on human health are complex and not fully understood, and some studies suggest that high intake of phytoestrogens may have adverse effects in certain populations or under specific conditions.

It is important to note that while phytoestrogens can mimic the effects of estrogen in the body, they are generally weaker than endogenous estrogens produced by the human body. Therefore, their impact on hormonal balance and health outcomes may vary depending on individual factors such as age, sex, hormonal status, and overall diet.

Hormone-dependent neoplasms are a type of tumor that requires the presence of specific hormones to grow and multiply. These neoplasms have receptors on their cell surfaces that bind to the hormones, leading to the activation of signaling pathways that promote cell division and growth.

Examples of hormone-dependent neoplasms include breast cancer, prostate cancer, and endometrial cancer. In breast cancer, for instance, estrogen and/or progesterone can bind to their respective receptors on the surface of cancer cells, leading to the activation of signaling pathways that promote tumor growth. Similarly, in prostate cancer, androgens such as testosterone can bind to androgen receptors on the surface of cancer cells, promoting cell division and tumor growth.

Hormone-dependent neoplasms are often treated with hormonal therapies that aim to reduce or block the production of the relevant hormones or interfere with their ability to bind to their respective receptors. This can help slow down or stop the growth of the tumor and improve outcomes for patients.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

Hydroxyestrones are metabolites of estrogens, which are female sex hormones. They are formed in the liver and other tissues when estrogens are broken down. Hydroxyestrones have weak estrogenic activity and can also act as antioxidants. Some hydroxyestrones, such as 2-hydroxyestrone and 4-hydroxyestrone, have been studied for their potential role in cancer development and progression, particularly hormone-dependent cancers like breast cancer. However, more research is needed to fully understand their effects on human health.

Aromatase inhibitors (AIs) are a class of drugs that are primarily used in the treatment of hormone-sensitive breast cancer in postmenopausal women. They work by inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogens. By blocking this conversion, AIs decrease the amount of estrogen in the body, thereby depriving hormone-sensitive breast cancer cells of the estrogen they need to grow and multiply.

There are three main types of aromatase inhibitors:

1. Letrozole (Femara) - a non-steroidal AI that is taken orally once a day.
2. Anastrozole (Arimidex) - another non-steroidal AI that is also taken orally once a day.
3. Exemestane (Aromasin) - a steroidal AI that is taken orally once a day.

In addition to their use in breast cancer treatment, AIs are also sometimes used off-label for the treatment of estrogen-dependent conditions such as endometriosis and uterine fibroids. However, it's important to note that the use of aromatase inhibitors can have significant side effects, including hot flashes, joint pain, and bone loss, so they should only be used under the close supervision of a healthcare provider.

Menopause is a natural biological process that typically occurs in women in their mid-40s to mid-50s. It marks the end of menstrual cycles and fertility, defined as the absence of menstruation for 12 consecutive months. This transition period can last several years and is often accompanied by various physical and emotional symptoms such as hot flashes, night sweats, mood changes, sleep disturbances, and vaginal dryness. The hormonal fluctuations during this time, particularly the decrease in estrogen levels, contribute to these symptoms. It's essential to monitor and manage these symptoms to maintain overall health and well-being during this phase of life.

Vitellogenins are a group of precursor proteins that are synthesized in the liver and subsequently transported to the ovaries, where they are taken up by developing oocytes. Once inside the oocyte, vitellogenins are cleaved into smaller proteins called lipovitellins and phosvitins, which play a crucial role in providing nutrients and energy to the developing embryo.

Vitellogenins are found in many oviparous species, including birds, reptiles, amphibians, fish, and some invertebrates. They are typically composed of several domains, including a large N-terminal domain that is rich in acidic amino acids, a central von Willebrand factor type D domain, and a C-terminal domain that contains multiple repeat units.

In addition to their role in egg development, vitellogenins have also been implicated in various physiological processes, such as immune function, stress response, and metal homeostasis. Moreover, the levels of vitellogenin in the blood can serve as a biomarker for environmental exposure to estrogenic compounds, as these chemicals can induce the synthesis of vitellogenins in male and juvenile animals.

A cell line that is derived from tumor cells and has been adapted to grow in culture. These cell lines are often used in research to study the characteristics of cancer cells, including their growth patterns, genetic changes, and responses to various treatments. They can be established from many different types of tumors, such as carcinomas, sarcomas, and leukemias. Once established, these cell lines can be grown and maintained indefinitely in the laboratory, allowing researchers to conduct experiments and studies that would not be feasible using primary tumor cells. It is important to note that tumor cell lines may not always accurately represent the behavior of the original tumor, as they can undergo genetic changes during their time in culture.

Antineoplastic agents, hormonal, are a class of drugs used to treat cancers that are sensitive to hormones. These agents work by interfering with the production or action of hormones in the body. They can be used to slow down or stop the growth of cancer cells and may also help to relieve symptoms caused by the spread of cancer.

Hormonal therapies can work in one of two ways: they can either block the production of hormones or prevent their action on cancer cells. For example, some hormonal therapies work by blocking the action of estrogen or testosterone, which are hormones that can stimulate the growth of certain types of cancer cells.

Examples of hormonal agents used to treat cancer include:

* Aromatase inhibitors (such as letrozole, anastrozole, and exemestane), which block the production of estrogen in postmenopausal women
* Selective estrogen receptor modulators (such as tamoxifen and raloxifene), which block the action of estrogen on cancer cells
* Luteinizing hormone-releasing hormone agonists (such as leuprolide, goserelin, and triptorelin), which block the production of testosterone in men
* Antiandrogens (such as bicalutamide, flutamide, and enzalutamide), which block the action of testosterone on cancer cells

Hormonal therapies are often used in combination with other treatments, such as surgery or radiation therapy. They may be used to shrink tumors before surgery, to kill any remaining cancer cells after surgery, or to help control the spread of cancer that cannot be removed by surgery. Hormonal therapies can also be used to relieve symptoms and improve quality of life in people with advanced cancer.

It's important to note that hormonal therapies are not effective for all types of cancer. They are most commonly used to treat breast, prostate, and endometrial cancers, which are known to be sensitive to hormones. Hormonal therapies may also be used to treat other types of cancer in certain situations.

Like all medications, hormonal therapies can have side effects. These can vary depending on the specific drug and the individual person. Common side effects of hormonal therapies include hot flashes, fatigue, mood changes, and sexual dysfunction. Some hormonal therapies can also cause more serious side effects, such as an increased risk of osteoporosis or blood clots. It's important to discuss the potential risks and benefits of hormonal therapy with a healthcare provider before starting treatment.

Nafoxidine is not typically included in general medical textbooks or resources as it is a relatively obscure and less commonly used medication. However, I was able to find some information on it in more specialized pharmacological references.

Nafoxidine is a non-selective antagonist of both α- and β-adrenergic receptors. It has been used in the past as an experimental drug for the treatment of various conditions, including alcohol withdrawal syndrome, opioid withdrawal syndrome, and hypertension (high blood pressure). However, due to its significant side effects and limited efficacy compared to other available treatments, it is no longer commonly used in clinical practice.

It's worth noting that Nafoxidine should not be confused with Naloxone or Naltrexone, which are opioid antagonists used for the treatment of opioid overdose and addiction, respectively.

Castration is a surgical procedure to remove the testicles in males or ovaries in females. In males, it is also known as orchiectomy. This procedure results in the inability to produce sex hormones and gametes (sperm in men and eggs in women), and can be done for various reasons such as medical treatment for certain types of cancer, to reduce sexual urges in individuals with criminal tendencies, or as a form of birth control in animals.

Gonadal steroid hormones, also known as gonadal sex steroids, are hormones that are produced and released by the gonads (i.e., ovaries in women and testes in men). These hormones play a critical role in the development and maintenance of secondary sexual characteristics, reproductive function, and overall health.

The three main classes of gonadal steroid hormones are:

1. Androgens: These are male sex hormones that are primarily produced by the testes but also produced in smaller amounts by the ovaries and adrenal glands. The most well-known androgen is testosterone, which plays a key role in the development of male secondary sexual characteristics such as facial hair, deepening of the voice, and increased muscle mass.
2. Estrogens: These are female sex hormones that are primarily produced by the ovaries but also produced in smaller amounts by the adrenal glands. The most well-known estrogen is estradiol, which plays a key role in the development of female secondary sexual characteristics such as breast development and the menstrual cycle.
3. Progestogens: These are hormones that are produced by the ovaries during the second half of the menstrual cycle and play a key role in preparing the uterus for pregnancy. The most well-known progestogen is progesterone, which also plays a role in maintaining pregnancy and regulating the menstrual cycle.

Gonadal steroid hormones can have significant effects on various physiological processes, including bone density, cognitive function, mood, and sexual behavior. Disorders of gonadal steroid hormone production or action can lead to a range of health problems, including infertility, osteoporosis, and sexual dysfunction.

Testosterone is a steroid hormone that belongs to androsten class of hormones. It is primarily secreted by the Leydig cells in the testes of males and, to a lesser extent, by the ovaries and adrenal glands in females. Testosterone is the main male sex hormone and anabolic steroid. It plays a key role in the development of masculine characteristics, such as body hair and muscle mass, and contributes to bone density, fat distribution, red cell production, and sex drive. In females, testosterone contributes to sexual desire and bone health. Testosterone is synthesized from cholesterol and its production is regulated by luteinizing hormone (LH) and follicle-stimulating hormone (FSH).

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Medroxyprogesterone Acetate (MPA) is a synthetic form of the natural hormone progesterone, which is often used in various medical applications. It is a white to off-white crystalline powder, slightly soluble in water, and freely soluble in alcohol, chloroform, and methanol.

Medically, MPA is used as a prescription medication for several indications, including:

1. Contraception: As an oral contraceptive or injectable solution, it can prevent ovulation, thicken cervical mucus to make it harder for sperm to reach the egg, and alter the lining of the uterus to make it less likely for a fertilized egg to implant.
2. Hormone replacement therapy (HRT): In postmenopausal women, MPA can help manage symptoms associated with decreased estrogen levels, such as hot flashes and vaginal dryness. It may also help prevent bone loss (osteoporosis).
3. Endometrial hyperplasia: MPA can be used to treat endometrial hyperplasia, a condition where the lining of the uterus becomes too thick, which could potentially lead to cancer if left untreated. By opposing the effects of estrogen, MPA helps regulate the growth of the endometrium.
4. Gynecological disorders: MPA can be used to treat various gynecological disorders, such as irregular menstrual cycles, amenorrhea (absence of menstruation), and dysfunctional uterine bleeding.
5. Cancer treatment: In some cases, MPA may be used in conjunction with other medications to treat certain types of breast or endometrial cancer.

As with any medication, Medroxyprogesterone Acetate can have side effects and potential risks. It is essential to consult a healthcare professional for proper evaluation, dosage, and monitoring when considering this medication.

Phenols, also known as phenolic acids or phenol derivatives, are a class of chemical compounds consisting of a hydroxyl group (-OH) attached to an aromatic hydrocarbon ring. In the context of medicine and biology, phenols are often referred to as a type of antioxidant that can be found in various foods and plants.

Phenols have the ability to neutralize free radicals, which are unstable molecules that can cause damage to cells and contribute to the development of chronic diseases such as cancer, heart disease, and neurodegenerative disorders. Some common examples of phenolic compounds include gallic acid, caffeic acid, ferulic acid, and ellagic acid, among many others.

Phenols can also have various pharmacological activities, including anti-inflammatory, antimicrobial, and analgesic effects. However, some phenolic compounds can also be toxic or irritating to the body in high concentrations, so their use as therapeutic agents must be carefully monitored and controlled.

Benzhydryl compounds are organic chemical compounds that contain the benzhydryl group, which is a functional group consisting of a diphenylmethane moiety. The benzhydryl group can be represented by the formula Ph2CH, where Ph represents the phenyl group (C6H5).

Benzhydryl compounds are characterized by their unique structure, which consists of two aromatic rings attached to a central carbon atom. This structure gives benzhydryl compounds unique chemical and physical properties, such as stability, rigidity, and high lipophilicity.

Benzhydryl compounds have various applications in organic synthesis, pharmaceuticals, and materials science. For example, they are used as building blocks in the synthesis of complex natural products, drugs, and functional materials. They also serve as useful intermediates in the preparation of other chemical compounds.

Some examples of benzhydryl compounds include diphenylmethane, benzphetamine, and diphenhydramine. These compounds have been widely used in medicine as stimulants, appetite suppressants, and antihistamines. However, some benzhydryl compounds have also been associated with potential health risks, such as liver toxicity and carcinogenicity, and their use should be carefully monitored and regulated.

Isoflavones are a type of plant-derived compounds called phytoestrogens, which have a chemical structure similar to human estrogen. They are found in various plants, particularly in soybeans and soy products. Isoflavones can act as weak estrogens or anti-estrogens in the body, depending on the levels of natural hormones present. These compounds have been studied for their potential health benefits, including reducing menopausal symptoms, improving cardiovascular health, and preventing certain types of cancer. However, more research is needed to fully understand their effects and safety.

Signal transduction is the process by which a cell converts an extracellular signal, such as a hormone or neurotransmitter, into an intracellular response. This involves a series of molecular events that transmit the signal from the cell surface to the interior of the cell, ultimately resulting in changes in gene expression, protein activity, or metabolism.

The process typically begins with the binding of the extracellular signal to a receptor located on the cell membrane. This binding event activates the receptor, which then triggers a cascade of intracellular signaling molecules, such as second messengers, protein kinases, and ion channels. These molecules amplify and propagate the signal, ultimately leading to the activation or inhibition of specific cellular responses.

Signal transduction pathways are highly regulated and can be modulated by various factors, including other signaling molecules, post-translational modifications, and feedback mechanisms. Dysregulation of these pathways has been implicated in a variety of diseases, including cancer, diabetes, and neurological disorders.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

"Response elements" is a term used in molecular biology, particularly in the study of gene regulation. Response elements are specific DNA sequences that can bind to transcription factors, which are proteins that regulate gene expression. When a transcription factor binds to a response element, it can either activate or repress the transcription of the nearby gene.

Response elements are often found in the promoter region of genes and are typically short, conserved sequences that can be recognized by specific transcription factors. The binding of a transcription factor to a response element can lead to changes in chromatin structure, recruitment of co-activators or co-repressors, and ultimately, the regulation of gene expression.

Response elements are important for many biological processes, including development, differentiation, and response to environmental stimuli such as hormones, growth factors, and stress. The specificity of transcription factor binding to response elements allows for precise control of gene expression in response to changing conditions within the cell or organism.

Estradiol receptors are a type of nuclear receptor protein that are activated by the hormone 17-β estradiol, which is a form of estrogen. These receptors are found in various tissues throughout the body, including the breasts, uterus, ovaries, prostate, and brain.

There are two main types of estradiol receptors, known as ERα and ERβ. Once activated by estradiol, these receptors function as transcription factors, binding to specific DNA sequences in the nucleus of cells and regulating the expression of target genes. This process plays a critical role in the development and maintenance of female sex characteristics, as well as in various physiological processes such as bone metabolism, cognitive function, and cardiovascular health.

Abnormalities in estradiol receptor signaling have been implicated in several diseases, including breast and endometrial cancers, osteoporosis, and neurological disorders. As a result, estradiol receptors are an important target for the development of therapies aimed at treating these conditions.

'Gene expression regulation' refers to the processes that control whether, when, and where a particular gene is expressed, meaning the production of a specific protein or functional RNA encoded by that gene. This complex mechanism can be influenced by various factors such as transcription factors, chromatin remodeling, DNA methylation, non-coding RNAs, and post-transcriptional modifications, among others. Proper regulation of gene expression is crucial for normal cellular function, development, and maintaining homeostasis in living organisms. Dysregulation of gene expression can lead to various diseases, including cancer and genetic disorders.

Genetic transcription is the process by which the information in a strand of DNA is used to create a complementary RNA molecule. This process is the first step in gene expression, where the genetic code in DNA is converted into a form that can be used to produce proteins or functional RNAs.

During transcription, an enzyme called RNA polymerase binds to the DNA template strand and reads the sequence of nucleotide bases. As it moves along the template, it adds complementary RNA nucleotides to the growing RNA chain, creating a single-stranded RNA molecule that is complementary to the DNA template strand. Once transcription is complete, the RNA molecule may undergo further processing before it can be translated into protein or perform its functional role in the cell.

Transcription can be either "constitutive" or "regulated." Constitutive transcription occurs at a relatively constant rate and produces essential proteins that are required for basic cellular functions. Regulated transcription, on the other hand, is subject to control by various intracellular and extracellular signals, allowing cells to respond to changing environmental conditions or developmental cues.

"Sex characteristics" refer to the anatomical, chromosomal, and genetic features that define males and females. These include both primary sex characteristics (such as reproductive organs like ovaries or testes) and secondary sex characteristics (such as breasts or facial hair) that typically develop during puberty. Sex characteristics are primarily determined by the presence of either X or Y chromosomes, with XX individuals usually developing as females and XY individuals usually developing as males, although variations and exceptions to this rule do occur.

Endocrine disruptors are defined as exogenous (external) substances or mixtures that interfere with the way hormones work in the body, leading to negative health effects. They can mimic, block, or alter the normal synthesis, secretion, transport, binding, action, or elimination of natural hormones in the body responsible for maintaining homeostasis, reproduction, development, and/or behavior.

Endocrine disruptors can be found in various sources, including industrial chemicals, pesticides, pharmaceuticals, and personal care products. They have been linked to a range of health problems, such as cancer, reproductive issues, developmental disorders, neurological impairments, and immune system dysfunction.

Examples of endocrine disruptors include bisphenol A (BPA), phthalates, dioxins, polychlorinated biphenyls (PCBs), perfluoroalkyl substances (PFAS), and certain pesticides like dichlorodiphenyltrichloroethane (DDT) and vinclozolin.

It is important to note that endocrine disruptors can have effects at very low doses, and their impact may depend on the timing of exposure, particularly during critical windows of development such as fetal growth and early childhood.

Androgens are a class of hormones that are primarily responsible for the development and maintenance of male sexual characteristics and reproductive function. Testosterone is the most well-known androgen, but other androgens include dehydroepiandrosterone (DHEA), androstenedione, and dihydrotestosterone (DHT).

Androgens are produced primarily by the testes in men and the ovaries in women, although small amounts are also produced by the adrenal glands in both sexes. They play a critical role in the development of male secondary sexual characteristics during puberty, such as the growth of facial hair, deepening of the voice, and increased muscle mass.

In addition to their role in sexual development and function, androgens also have important effects on bone density, mood, and cognitive function. Abnormal levels of androgens can contribute to a variety of medical conditions, including infertility, erectile dysfunction, acne, hirsutism (excessive hair growth), and prostate cancer.

Neoplastic gene expression regulation refers to the processes that control the production of proteins and other molecules from genes in neoplastic cells, or cells that are part of a tumor or cancer. In a normal cell, gene expression is tightly regulated to ensure that the right genes are turned on or off at the right time. However, in cancer cells, this regulation can be disrupted, leading to the overexpression or underexpression of certain genes.

Neoplastic gene expression regulation can be affected by a variety of factors, including genetic mutations, epigenetic changes, and signals from the tumor microenvironment. These changes can lead to the activation of oncogenes (genes that promote cancer growth and development) or the inactivation of tumor suppressor genes (genes that prevent cancer).

Understanding neoplastic gene expression regulation is important for developing new therapies for cancer, as targeting specific genes or pathways involved in this process can help to inhibit cancer growth and progression.

The endometrium is the innermost layer of the uterus, which lines the uterine cavity and has a critical role in the menstrual cycle and pregnancy. It is composed of glands and blood vessels that undergo cyclic changes under the influence of hormones, primarily estrogen and progesterone. During the menstrual cycle, the endometrium thickens in preparation for a potential pregnancy. If fertilization does not occur, it will break down and be shed, resulting in menstruation. In contrast, if implantation takes place, the endometrium provides essential nutrients to support the developing embryo and placenta throughout pregnancy.

Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a laboratory technique used in molecular biology to amplify and detect specific DNA sequences. This technique is particularly useful for the detection and quantification of RNA viruses, as well as for the analysis of gene expression.

The process involves two main steps: reverse transcription and polymerase chain reaction (PCR). In the first step, reverse transcriptase enzyme is used to convert RNA into complementary DNA (cDNA) by reading the template provided by the RNA molecule. This cDNA then serves as a template for the PCR amplification step.

In the second step, the PCR reaction uses two primers that flank the target DNA sequence and a thermostable polymerase enzyme to repeatedly copy the targeted cDNA sequence. The reaction mixture is heated and cooled in cycles, allowing the primers to anneal to the template, and the polymerase to extend the new strand. This results in exponential amplification of the target DNA sequence, making it possible to detect even small amounts of RNA or cDNA.

RT-PCR is a sensitive and specific technique that has many applications in medical research and diagnostics, including the detection of viruses such as HIV, hepatitis C virus, and SARS-CoV-2 (the virus that causes COVID-19). It can also be used to study gene expression, identify genetic mutations, and diagnose genetic disorders.

Androgen receptors (ARs) are a type of nuclear receptor protein that are expressed in various tissues throughout the body. They play a critical role in the development and maintenance of male sexual characteristics and reproductive function. ARs are activated by binding to androgens, which are steroid hormones such as testosterone and dihydrotestosterone (DHT). Once activated, ARs function as transcription factors that regulate gene expression, ultimately leading to various cellular responses.

In the context of medical definitions, androgen receptors can be defined as follows:

Androgen receptors are a type of nuclear receptor protein that bind to androgens, such as testosterone and dihydrotestosterone, and mediate their effects on gene expression in various tissues. They play critical roles in the development and maintenance of male sexual characteristics and reproductive function, and are involved in the pathogenesis of several medical conditions, including prostate cancer, benign prostatic hyperplasia, and androgen deficiency syndromes.

A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.

The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.

The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.

In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.

'Tumor cells, cultured' refers to the process of removing cancerous cells from a tumor and growing them in controlled laboratory conditions. This is typically done by isolating the tumor cells from a patient's tissue sample, then placing them in a nutrient-rich environment that promotes their growth and multiplication.

The resulting cultured tumor cells can be used for various research purposes, including the study of cancer biology, drug development, and toxicity testing. They provide a valuable tool for researchers to better understand the behavior and characteristics of cancer cells outside of the human body, which can lead to the development of more effective cancer treatments.

It is important to note that cultured tumor cells may not always behave exactly the same way as they do in the human body, so findings from cell culture studies must be validated through further research, such as animal models or clinical trials.

An ovary is a part of the female reproductive system in which ova or eggs are produced through the process of oogenesis. They are a pair of solid, almond-shaped structures located one on each side of the uterus within the pelvic cavity. Each ovary measures about 3 to 5 centimeters in length and weighs around 14 grams.

The ovaries have two main functions: endocrine (hormonal) function and reproductive function. They produce and release eggs (ovulation) responsible for potential fertilization and development of an embryo/fetus during pregnancy. Additionally, they are essential in the production of female sex hormones, primarily estrogen and progesterone, which regulate menstrual cycles, sexual development, and reproduction.

During each menstrual cycle, a mature egg is released from one of the ovaries into the fallopian tube, where it may be fertilized by sperm. If not fertilized, the egg, along with the uterine lining, will be shed, leading to menstruation.

The breast is the upper ventral region of the human body in females, which contains the mammary gland. The main function of the breast is to provide nutrition to infants through the production and secretion of milk, a process known as lactation. The breast is composed of fibrous connective tissue, adipose (fatty) tissue, and the mammary gland, which is made up of 15-20 lobes that are arranged in a radial pattern. Each lobe contains many smaller lobules, where milk is produced during lactation. The milk is then transported through a network of ducts to the nipple, where it can be expressed by the infant.

In addition to its role in lactation, the breast also has important endocrine and psychological functions. It contains receptors for hormones such as estrogen and progesterone, which play a key role in sexual development and reproduction. The breast is also a source of sexual pleasure and can be an important symbol of femininity and motherhood.

It's worth noting that males also have breast tissue, although it is usually less developed than in females. Male breast tissue consists mainly of adipose tissue and does not typically contain functional mammary glands. However, some men may develop enlarged breast tissue due to conditions such as gynecomastia, which can be caused by hormonal imbalances or certain medications.

The estrous cycle is the reproductive cycle in certain mammals, characterized by regular changes in the reproductive tract and behavior, which are regulated by hormonal fluctuations. It is most commonly observed in non-primate mammals such as dogs, cats, cows, pigs, and horses.

The estrous cycle consists of several stages:

1. Proestrus: This stage lasts for a few days and is characterized by the development of follicles in the ovaries and an increase in estrogen levels. During this time, the female may show signs of sexual receptivity, but will not allow mating to occur.
2. Estrus: This is the period of sexual receptivity, during which the female allows mating to take place. It typically lasts for a few days and is marked by a surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which triggers ovulation.
3. Metestrus: This stage follows ovulation and is characterized by the formation of a corpus luteum, a structure that produces progesterone to support pregnancy. If fertilization does not occur, the corpus luteum will eventually regress, leading to the next phase.
4. Diestrus: This is the final stage of the estrous cycle and can last for several weeks or months. During this time, the female's reproductive tract returns to its resting state, and she is not sexually receptive. If pregnancy has occurred, the corpus luteum will continue to produce progesterone until the placenta takes over this function later in pregnancy.

It's important to note that the human menstrual cycle is different from the estrous cycle. While both cycles involve hormonal fluctuations and changes in the reproductive tract, the menstrual cycle includes a shedding of the uterine lining (menstruation) if fertilization does not occur, which is not a feature of the estrous cycle.

Hormone Replacement Therapy (HRT) is a medical treatment that involves the use of hormones to replace or supplement those that the body is no longer producing or no longer producing in sufficient quantities. It is most commonly used to help manage symptoms associated with menopause and conditions related to hormonal imbalances.

In women, HRT typically involves the use of estrogen and/or progesterone to alleviate hot flashes, night sweats, vaginal dryness, and mood changes that can occur during menopause. In some cases, testosterone may also be prescribed to help improve energy levels, sex drive, and overall sense of well-being.

In men, HRT is often used to treat low testosterone levels (hypogonadism) and related symptoms such as fatigue, decreased muscle mass, and reduced sex drive.

It's important to note that while HRT can be effective in managing certain symptoms, it also carries potential risks, including an increased risk of blood clots, stroke, breast cancer (in women), and cardiovascular disease. Therefore, the decision to undergo HRT should be made carefully and discussed thoroughly with a healthcare provider.

Oviducts, also known as fallopian tubes in humans, are pair of slender tubular structures that serve as the conduit for the ovum (egg) from the ovaries to the uterus. They are an essential part of the female reproductive system, providing a site for fertilization of the egg by sperm and early embryonic development before the embryo moves into the uterus for further growth.

In medical terminology, the term "oviduct" refers to this functional description rather than a specific anatomical structure in all female organisms. The oviducts vary in length and shape across different species, but their primary role remains consistent: to facilitate the transport of the egg and provide a site for fertilization.

Premenopause is not a formal medical term, but it's often informally used to refer to the time period in a woman's life leading up to menopause. During this stage, which can last for several years, hormonal changes begin to occur in preparation for menopause. The ovaries start to produce less estrogen and progesterone, which can lead to various symptoms such as irregular periods, hot flashes, mood swings, and sleep disturbances. However, it's important to note that not all women will experience these symptoms.

The official medical term for the stage when a woman's period becomes irregular and less frequent, but hasn't stopped completely, is perimenopause. This stage typically lasts from two to eight years and ends with menopause, which is defined as the point when a woman has not had a period for 12 consecutive months. After menopause, women enter postmenopause.

Equilenin is an estrogen compound that is found in certain plants and is also produced synthetically. It is structurally similar to the natural estrogens produced by the human body, such as estradiol and estrone. Equilenin has been used in some forms of hormone replacement therapy and in the treatment of certain medical conditions, such as breast cancer and prostate cancer. However, its use is not as common as other synthetic estrogens due to its potential side effects and risks.

Like other estrogen compounds, equilenin works by binding to estrogen receptors in the body, which are found in various tissues including the breasts, uterus, bones, and brain. This binding action can stimulate cell growth and development, as well as regulate various physiological processes such as bone density, cholesterol levels, and mood.

It is important to note that the use of estrogen therapy, including equilenin, carries certain risks, particularly for postmenopausal women. Long-term use of estrogen therapy has been associated with an increased risk of breast cancer, endometrial cancer, stroke, and blood clots. Therefore, it should only be used under the close supervision of a healthcare provider and for the shortest duration necessary to treat the underlying medical condition.

A drug implant is a medical device that is specially designed to provide controlled release of a medication into the body over an extended period of time. Drug implants can be placed under the skin or in various body cavities, depending on the specific medical condition being treated. They are often used when other methods of administering medication, such as oral pills or injections, are not effective or practical.

Drug implants come in various forms, including rods, pellets, and small capsules. The medication is contained within the device and is released slowly over time, either through diffusion or erosion of the implant material. This allows for a steady concentration of the drug to be maintained in the body, which can help to improve treatment outcomes and reduce side effects.

Some common examples of drug implants include:

1. Hormonal implants: These are small rods that are inserted under the skin of the upper arm and release hormones such as progestin or estrogen over a period of several years. They are often used for birth control or to treat conditions such as endometriosis or uterine fibroids.
2. Intraocular implants: These are small devices that are placed in the eye during surgery to release medication directly into the eye. They are often used to treat conditions such as age-related macular degeneration or diabetic retinopathy.
3. Bone cement implants: These are specially formulated cements that contain antibiotics and are used to fill bone defects or joint spaces during surgery. The antibiotics are released slowly over time, helping to prevent infection.
4. Implantable pumps: These are small devices that are placed under the skin and deliver medication directly into a specific body cavity, such as the spinal cord or the peritoneal cavity. They are often used to treat chronic pain or cancer.

Overall, drug implants offer several advantages over other methods of administering medication, including improved compliance, reduced side effects, and more consistent drug levels in the body. However, they may also have some disadvantages, such as the need for surgical placement and the potential for infection or other complications. As with any medical treatment, it is important to discuss the risks and benefits of drug implants with a healthcare provider.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Cell proliferation is the process by which cells increase in number, typically through the process of cell division. In the context of biology and medicine, it refers to the reproduction of cells that makes up living tissue, allowing growth, maintenance, and repair. It involves several stages including the transition from a phase of quiescence (G0 phase) to an active phase (G1 phase), DNA replication in the S phase, and mitosis or M phase, where the cell divides into two daughter cells.

Abnormal or uncontrolled cell proliferation is a characteristic feature of many diseases, including cancer, where deregulated cell cycle control leads to excessive and unregulated growth of cells, forming tumors that can invade surrounding tissues and metastasize to distant sites in the body.

Dihydrotestosterone (DHT) is a sex hormone and androgen that plays a critical role in the development and maintenance of male characteristics, such as facial hair, deep voice, and muscle mass. It is synthesized from testosterone through the action of the enzyme 5-alpha reductase. DHT is essential for the normal development of the male genitalia during fetal development and for the maturation of the sexual organs at puberty.

In addition to its role in sexual development, DHT also contributes to the growth of hair follicles, the health of the prostate gland, and the maintenance of bone density. However, an excess of DHT has been linked to certain medical conditions, such as benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness).

DHT exerts its effects by binding to androgen receptors in various tissues throughout the body. Once bound, DHT triggers a series of cellular responses that regulate gene expression and influence the growth and differentiation of cells. In some cases, these responses can lead to unwanted side effects, such as hair loss or prostate enlargement.

Medications that block the action of 5-alpha reductase, such as finasteride and dutasteride, are sometimes used to treat conditions associated with excess DHT production. These drugs work by reducing the amount of DHT available to bind to androgen receptors, thereby alleviating symptoms and slowing disease progression.

In summary, dihydrotestosterone is a potent sex hormone that plays a critical role in male sexual development and function. While it is essential for normal growth and development, an excess of DHT has been linked to certain medical conditions, such as BPH and androgenetic alopecia. Medications that block the action of 5-alpha reductase are sometimes used to treat these conditions by reducing the amount of DHT available to bind to androgen receptors.

Promoter regions in genetics refer to specific DNA sequences located near the transcription start site of a gene. They serve as binding sites for RNA polymerase and various transcription factors that regulate the initiation of gene transcription. These regulatory elements help control the rate of transcription and, therefore, the level of gene expression. Promoter regions can be composed of different types of sequences, such as the TATA box and CAAT box, and their organization and composition can vary between different genes and species.

Hexestrol is a synthetic, non-steroidal estrogen that was previously used in various medical treatments, including hormone replacement therapy and the treatment of certain types of cancer. It is no longer commonly used in clinical medicine due to its associated side effects and the availability of safer and more effective alternatives. Hexestrol is classified as a carcinogen and may increase the risk of certain cancers, particularly endometrial and breast cancer. It is important to note that the use of hexestrol and other synthetic estrogens should be under the supervision of a healthcare professional, and it is not recommended for self-medication.

Endometrial neoplasms refer to abnormal growths or tumors in the endometrium, which is the innermost lining of the uterus. These neoplasms can be benign (non-cancerous) or malignant (cancerous). The two main types of endometrial cancer are type I, also known as endometrioid adenocarcinoma, and type II, which includes serous carcinoma, clear cell carcinoma, and carcinosarcoma.

Type I endometrial cancers are usually estrogen-dependent and associated with risk factors such as obesity, diabetes, and prolonged exposure to estrogen without progesterone. They tend to grow more slowly and have a better prognosis than type II cancers.

Type II endometrial cancers are less common but more aggressive, often presenting at an advanced stage and having a worse prognosis. They are not typically associated with hormonal factors and may occur in women who have gone through menopause.

Endometrial neoplasms can also include benign growths such as polyps, hyperplasia, and endometriosis. While these conditions are not cancerous, they can increase the risk of developing endometrial cancer and should be monitored closely by a healthcare provider.

The menstrual cycle is a series of natural changes that occur in the female reproductive system over an approximate 28-day interval, marking the body's preparation for potential pregnancy. It involves the interplay of hormones that regulate the growth and disintegration of the uterine lining (endometrium) and the release of an egg (ovulation) from the ovaries.

The menstrual cycle can be divided into three main phases:

1. Menstrual phase: The cycle begins with the onset of menstruation, where the thickened uterine lining is shed through the vagina, lasting typically for 3-7 days. This shedding occurs due to a decrease in estrogen and progesterone levels, which are hormones essential for maintaining the endometrium during the previous cycle.

2. Follicular phase: After menstruation, the follicular phase commences with the pituitary gland releasing follicle-stimulating hormone (FSH). FSH stimulates the growth of several ovarian follicles, each containing an immature egg. One dominant follicle usually becomes selected to mature and release an egg during ovulation. Estrogen levels rise as the dominant follicle grows, causing the endometrium to thicken in preparation for a potential pregnancy.

3. Luteal phase: Following ovulation, the ruptured follicle transforms into the corpus luteum, which produces progesterone and estrogen to further support the endometrial thickening. If fertilization does not occur within approximately 24 hours after ovulation, the corpus luteum will degenerate, leading to a decline in hormone levels. This drop triggers the onset of menstruation, initiating a new menstrual cycle.

Understanding the menstrual cycle is crucial for monitoring reproductive health and planning or preventing pregnancies. Variations in cycle length and symptoms are common among women, but persistent irregularities may indicate underlying medical conditions requiring further evaluation by a healthcare professional.

Medroxyprogesterone is a synthetic form of the natural hormone progesterone, which is a female sex hormone produced by the corpus luteum during the menstrual cycle and by the placenta during pregnancy. As a medication, medroxyprogesterone is used to treat a variety of conditions, including:

* Abnormal menstrual bleeding
* Endometrial hyperplasia (overgrowth of the lining of the uterus)
* Contraception (birth control)
* Hormone replacement therapy in postmenopausal women
* Prevention of breast cancer in high-risk women
* Treatment of certain types of cancer, such as endometrial and renal cancers

Medroxyprogesterone works by binding to progesterone receptors in the body, which helps to regulate the menstrual cycle, maintain pregnancy, and prevent the growth of some types of cancer. It is available in various forms, including tablets, injectable solutions, and depot suspensions for intramuscular injection.

It's important to note that medroxyprogesterone can have significant side effects, and its use should be monitored by a healthcare provider. Women who are pregnant or breastfeeding should not take medroxyprogesterone, and it may interact with other medications, so it is important to inform your doctor of all medications you are taking before starting medroxyprogesterone.

Transcriptional activation is the process by which a cell increases the rate of transcription of specific genes from DNA to RNA. This process is tightly regulated and plays a crucial role in various biological processes, including development, differentiation, and response to environmental stimuli.

Transcriptional activation occurs when transcription factors (proteins that bind to specific DNA sequences) interact with the promoter region of a gene and recruit co-activator proteins. These co-activators help to remodel the chromatin structure around the gene, making it more accessible for the transcription machinery to bind and initiate transcription.

Transcriptional activation can be regulated at multiple levels, including the availability and activity of transcription factors, the modification of histone proteins, and the recruitment of co-activators or co-repressors. Dysregulation of transcriptional activation has been implicated in various diseases, including cancer and genetic disorders.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

'Mammary neoplasms, experimental' is not a recognized medical term. However, I can provide definitions for the individual terms:

1. Mammary: Pertaining to the breast or mammary glands in females, which are responsible for milk production.
2. Neoplasms: Abnormal growths of tissue, also known as tumors or masses, that can be benign (non-cancerous) or malignant (cancerous).
3. Experimental: Relating to a scientific experiment or study, typically conducted in a controlled setting to test hypotheses and gather data.

In the context of medical research, 'experimental mammary neoplasms' may refer to artificially induced breast tumors in laboratory animals (such as rats or mice) for the purpose of studying the development, progression, treatment, and prevention of breast cancer. These studies can help researchers better understand the biology of breast cancer and develop new therapies and strategies for its diagnosis and management.

"ErbB-2" is also known as "HER2" or "human epidermal growth factor receptor 2." It is a type of receptor tyrosine kinase (RTK) found on the surface of some cells. ErbB-2 does not bind to any known ligands, but it can form heterodimers with other ErbB family members, such as ErbB-3 and ErbB-4, which do have identified ligands. When a ligand binds to one of these receptors, it causes a conformational change that allows the ErbB-2 receptor to become activated through transphosphorylation. This activation triggers a signaling cascade that regulates cell growth, differentiation, and survival.

Overexpression or amplification of the ERBB2 gene, which encodes the ErbB-2 protein, is observed in approximately 20-30% of breast cancers and is associated with a more aggressive disease phenotype and poorer prognosis. Therefore, ErbB-2 has become an important target for cancer therapy, and several drugs that target this receptor have been developed, including trastuzumab (Herceptin), lapatinib (Tykerb), and pertuzumab (Perjeta).

Western blotting is a laboratory technique used in molecular biology to detect and quantify specific proteins in a mixture of many different proteins. This technique is commonly used to confirm the expression of a protein of interest, determine its size, and investigate its post-translational modifications. The name "Western" blotting distinguishes this technique from Southern blotting (for DNA) and Northern blotting (for RNA).

The Western blotting procedure involves several steps:

1. Protein extraction: The sample containing the proteins of interest is first extracted, often by breaking open cells or tissues and using a buffer to extract the proteins.
2. Separation of proteins by electrophoresis: The extracted proteins are then separated based on their size by loading them onto a polyacrylamide gel and running an electric current through the gel (a process called sodium dodecyl sulfate-polyacrylamide gel electrophoresis or SDS-PAGE). This separates the proteins according to their molecular weight, with smaller proteins migrating faster than larger ones.
3. Transfer of proteins to a membrane: After separation, the proteins are transferred from the gel onto a nitrocellulose or polyvinylidene fluoride (PVDF) membrane using an electric current in a process called blotting. This creates a replica of the protein pattern on the gel but now immobilized on the membrane for further analysis.
4. Blocking: The membrane is then blocked with a blocking agent, such as non-fat dry milk or bovine serum albumin (BSA), to prevent non-specific binding of antibodies in subsequent steps.
5. Primary antibody incubation: A primary antibody that specifically recognizes the protein of interest is added and allowed to bind to its target protein on the membrane. This step may be performed at room temperature or 4°C overnight, depending on the antibody's properties.
6. Washing: The membrane is washed with a buffer to remove unbound primary antibodies.
7. Secondary antibody incubation: A secondary antibody that recognizes the primary antibody (often coupled to an enzyme or fluorophore) is added and allowed to bind to the primary antibody. This step may involve using a horseradish peroxidase (HRP)-conjugated or alkaline phosphatase (AP)-conjugated secondary antibody, depending on the detection method used later.
8. Washing: The membrane is washed again to remove unbound secondary antibodies.
9. Detection: A detection reagent is added to visualize the protein of interest by detecting the signal generated from the enzyme-conjugated or fluorophore-conjugated secondary antibody. This can be done using chemiluminescent, colorimetric, or fluorescent methods.
10. Analysis: The resulting image is analyzed to determine the presence and quantity of the protein of interest in the sample.

Western blotting is a powerful technique for identifying and quantifying specific proteins within complex mixtures. It can be used to study protein expression, post-translational modifications, protein-protein interactions, and more. However, it requires careful optimization and validation to ensure accurate and reproducible results.

"Plant preparations" is not a term with a specific medical definition in the field of medicine or pharmacology. However, it is commonly used to refer to various forms of plant material that have been prepared for medicinal use. This can include dried and powdered plant parts, such as leaves, roots, or flowers, as well as extracts or concentrates made from plants. These preparations may be used in traditional medicine or as the basis for modern pharmaceuticals. It is important to note that the safety, effectiveness, and quality of plant preparations can vary widely, and they should only be used under the guidance of a qualified healthcare provider.

Cell division is the process by which a single eukaryotic cell (a cell with a true nucleus) divides into two identical daughter cells. This complex process involves several stages, including replication of DNA, separation of chromosomes, and division of the cytoplasm. There are two main types of cell division: mitosis and meiosis.

Mitosis is the type of cell division that results in two genetically identical daughter cells. It is a fundamental process for growth, development, and tissue repair in multicellular organisms. The stages of mitosis include prophase, prometaphase, metaphase, anaphase, and telophase, followed by cytokinesis, which divides the cytoplasm.

Meiosis, on the other hand, is a type of cell division that occurs in the gonads (ovaries and testes) during the production of gametes (sex cells). Meiosis results in four genetically unique daughter cells, each with half the number of chromosomes as the parent cell. This process is essential for sexual reproduction and genetic diversity. The stages of meiosis include meiosis I and meiosis II, which are further divided into prophase, prometaphase, metaphase, anaphase, and telophase.

In summary, cell division is the process by which a single cell divides into two daughter cells, either through mitosis or meiosis. This process is critical for growth, development, tissue repair, and sexual reproduction in multicellular organisms.

Estradiol dehydrogenases are a group of enzymes that are involved in the metabolism of estradiols, which are steroid hormones that play important roles in the development and maintenance of female reproductive system and secondary sexual characteristics. These enzymes catalyze the oxidation or reduction reactions of estradiols, converting them to other forms of steroid hormones.

There are two main types of estradiol dehydrogenases: 1) 3-alpha-hydroxysteroid dehydrogenase (3-alpha HSD), which catalyzes the conversion of estradi-17-beta to estrone, and 2) 17-beta-hydroxysteroid dehydrogenase (17-beta HSD), which catalyzes the reverse reaction, converting estrone back to estradiol.

These enzymes are widely distributed in various tissues, including the ovaries, placenta, liver, and adipose tissue, and play important roles in regulating the levels of estradiols in the body. Abnormalities in the activity of these enzymes have been associated with several medical conditions, such as hormone-dependent cancers, polycystic ovary syndrome, and hirsutism.

MCF-7 cells are a type of human breast cancer cell line that was originally isolated from a patient with metastatic breast cancer. The acronym "MCF" stands for Michigan Cancer Foundation, which is the institution where the cell line was developed. The number "7" refers to the seventh and final passage of the original tumor sample that was used to establish the cell line.

MCF-7 cells are estrogen receptor (ER) and progesterone receptor (PR) positive, which means they have receptors for these hormones on their surface. This makes them a useful tool for studying the effects of hormonal therapies on breast cancer cells. They also express other markers associated with breast cancer, such as HER2/neu and E-cadherin.

MCF-7 cells are widely used in breast cancer research to study various aspects of the disease, including cell growth and division, invasion and metastasis, and response to therapies. They can be grown in culture dishes or flasks and are often used for experiments that involve treating cells with drugs, infecting them with viruses, or manipulating their genes using techniques such as RNA interference.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

A ligand, in the context of biochemistry and medicine, is a molecule that binds to a specific site on a protein or a larger biomolecule, such as an enzyme or a receptor. This binding interaction can modify the function or activity of the target protein, either activating it or inhibiting it. Ligands can be small molecules, like hormones or neurotransmitters, or larger structures, like antibodies. The study of ligand-protein interactions is crucial for understanding cellular processes and developing drugs, as many therapeutic compounds function by binding to specific targets within the body.

17-Hydroxysteroid dehydrogenases (17-HSDs) are a group of enzymes that play a crucial role in steroid hormone biosynthesis. They are involved in the conversion of 17-ketosteroids to 17-hydroxy steroids or vice versa, by adding or removing a hydroxyl group (–OH) at the 17th carbon atom of the steroid molecule. This conversion is essential for the production of various steroid hormones, including cortisol, aldosterone, and sex hormones such as estrogen and testosterone.

There are several isoforms of 17-HSDs, each with distinct substrate specificities, tissue distributions, and functions:

1. 17-HSD type 1 (17-HSD1): This isoform primarily catalyzes the conversion of estrone (E1) to estradiol (E2), an active form of estrogen. It is mainly expressed in the ovary, breast, and adipose tissue.
2. 17-HSD type 2 (17-HSD2): This isoform catalyzes the reverse reaction, converting estradiol (E2) to estrone (E1). It is primarily expressed in the placenta, prostate, and breast tissue.
3. 17-HSD type 3 (17-HSD3): This isoform is responsible for the conversion of androstenedione to testosterone, an essential step in male sex hormone biosynthesis. It is predominantly expressed in the testis and adrenal gland.
4. 17-HSD type 4 (17-HSD4): This isoform catalyzes the conversion of dehydroepiandrosterone (DHEA) to androstenedione, an intermediate step in steroid hormone biosynthesis. It is primarily expressed in the placenta.
5. 17-HSD type 5 (17-HSD5): This isoform catalyzes the conversion of cortisone to cortisol, a critical step in glucocorticoid biosynthesis. It is predominantly expressed in the adrenal gland and liver.
6. 17-HSD type 6 (17-HSD6): This isoform catalyzes the conversion of androstenedione to testosterone, similar to 17-HSD3. However, it has a different substrate specificity and is primarily expressed in the ovary.
7. 17-HSD type 7 (17-HSD7): This isoform catalyzes the conversion of estrone (E1) to estradiol (E2), similar to 17-HSD1. However, it has a different substrate specificity and is primarily expressed in the ovary.
8. 17-HSD type 8 (17-HSD8): This isoform catalyzes the conversion of DHEA to androstenedione, similar to 17-HSD4. However, it has a different substrate specificity and is primarily expressed in the testis.
9. 17-HSD type 9 (17-HSD9): This isoform catalyzes the conversion of estrone (E1) to estradiol (E2), similar to 17-HSD1. However, it has a different substrate specificity and is primarily expressed in the placenta.
10. 17-HSD type 10 (17-HSD10): This isoform catalyzes the conversion of DHEA to androstenedione, similar to 17-HSD4. However, it has a different substrate specificity and is primarily expressed in the testis.
11. 17-HSD type 11 (17-HSD11): This isoform catalyzes the conversion of estrone (E1) to estradiol (E2), similar to 17-HSD1. However, it has a different substrate specificity and is primarily expressed in the placenta.
12. 17-HSD type 12 (17-HSD12): This isoform catalyzes the conversion of DHEA to androstenedione, similar to 17-HSD4. However, it has a different substrate specificity and is primarily expressed in the testis.
13. 17-HSD type 13 (17-HSD13): This isoform catalyzes the conversion of estrone (E1) to estradiol (E2), similar to 17-HSD1. However, it has a different substrate specificity and is primarily expressed in the placenta.
14. 17-HSD type 14 (17-HSD14): This isoform catalyzes the conversion of DHEA to androstenedione, similar to 17-HSD4. However, it has a different substrate specificity and is primarily expressed in the testis.
15. 17-HSD type 15 (17-HSD15): This isoform catalyzes the conversion of estrone (E1) to estradiol (E2), similar to 17-HSD1. However, it has a different substrate specificity and is primarily expressed in the placenta.
16. 17-HSD type 16 (17-HSD16): This isoform catalyzes the conversion of DHEA to androstenedione, similar to 17-HSD4. However, it has a different substrate specificity and is primarily expressed in the testis.
17. 17-HSD type 17 (17-HSD17): This isoform catalyzes the conversion of estrone (E1) to estradiol (E2), similar to 17-HSD1. However, it has a different substrate specificity and is primarily expressed in the placenta.
18. 17-HSD type 18 (17-HSD18): This isoform catalyzes the conversion of DHEA to androstenedione, similar to 17-HSD4. However, it has a different substrate specificity and is primarily expressed in the testis.
19. 17-HSD type 19 (17-HSD19): This isoform catalyzes the conversion of estrone (E1) to estradiol (E2), similar to 17-HSD1. However, it has a different substrate specificity and is primarily expressed in the placenta.
20. 17-HSD type 20 (17-HSD20): This isoform catalyzes the conversion of DHEA to androstenedione, similar to 17-HSD4. However, it has a different substrate specificity and is primarily expressed in the testis.
21. 17-HSD type 21 (17-HSD21): This isoform catalyzes the conversion of estrone (E1) to estradiol (E2), similar to 17-HSD1. However, it has a different substrate specificity and is primarily expressed in the placenta.
22. 17-HSD type 22 (17-HSD22): This isoform catalyzes the conversion of DHEA to androstenedione, similar to 17-HSD4. However, it has a different substrate specificity and is primarily expressed in the testis.
23. 17-HSD type 23 (17-HSD23): This isoform catalyzes the conversion of estrone (E1) to estradiol (E2), similar to 17-HSD1. However, it has a different substrate specificity and is primarily expressed in the placenta.
24. 17-HSD type 24 (17-HSD24): This isoform catalyzes the conversion of DHEA to androstenedione, similar to 17-HSD4. However, it has a different substrate specificity and is primarily expressed in the testis.
25. 17-HSD type 25 (17-HSD25): This isoform catalyzes the conversion of estrone (E1) to estradiol (E2), similar to 17-HSD1. However, it has a different substrate specificity and is primarily expressed in the placenta.
26. 17-HSD type 26 (17-HSD26): This isoform catalyzes the conversion of DHEA to androstenedione, similar to 17-HSD4. However

Organ size refers to the volume or physical measurement of an organ in the body of an individual. It can be described in terms of length, width, and height or by using specialized techniques such as imaging studies (like CT scans or MRIs) to determine the volume. The size of an organ can vary depending on factors such as age, sex, body size, and overall health status. Changes in organ size may indicate various medical conditions, including growths, inflammation, or atrophy.

Prolactin is a hormone produced by the pituitary gland, a small gland located at the base of the brain. Its primary function is to stimulate milk production in women after childbirth, a process known as lactation. However, prolactin also plays other roles in the body, including regulating immune responses, metabolism, and behavior. In men, prolactin helps maintain the sexual glands and contributes to paternal behaviors.

Prolactin levels are usually low in both men and non-pregnant women but increase significantly during pregnancy and after childbirth. Various factors can affect prolactin levels, including stress, sleep, exercise, and certain medications. High prolactin levels can lead to medical conditions such as amenorrhea (absence of menstruation), galactorrhea (spontaneous milk production not related to childbirth), infertility, and reduced sexual desire in both men and women.

Gene expression is the process by which the information encoded in a gene is used to synthesize a functional gene product, such as a protein or RNA molecule. This process involves several steps: transcription, RNA processing, and translation. During transcription, the genetic information in DNA is copied into a complementary RNA molecule, known as messenger RNA (mRNA). The mRNA then undergoes RNA processing, which includes adding a cap and tail to the mRNA and splicing out non-coding regions called introns. The resulting mature mRNA is then translated into a protein on ribosomes in the cytoplasm through the process of translation.

The regulation of gene expression is a complex and highly controlled process that allows cells to respond to changes in their environment, such as growth factors, hormones, and stress signals. This regulation can occur at various stages of gene expression, including transcriptional activation or repression, RNA processing, mRNA stability, and translation. Dysregulation of gene expression has been implicated in many diseases, including cancer, genetic disorders, and neurological conditions.

Mammary glands are specialized exocrine glands found in mammals, including humans and other animals. These glands are responsible for producing milk, which is used to nurse offspring after birth. The mammary glands are located in the breast region of female mammals and are usually rudimentary or absent in males.

In animals, mammary glands can vary in number and location depending on the species. For example, humans and other primates have two mammary glands, one in each breast. Cows, goats, and sheep, on the other hand, have multiple pairs of mammary glands located in their lower abdominal region.

Mammary glands are made up of several structures, including lobules, ducts, and connective tissue. The lobules contain clusters of milk-secreting cells called alveoli, which produce and store milk. The ducts transport the milk from the lobules to the nipple, where it is released during lactation.

Mammary glands are an essential feature of mammals, as they provide a source of nutrition for newborn offspring. They also play a role in the development and maintenance of the mother-infant bond, as nursing provides opportunities for physical contact and bonding between the mother and her young.

Transfection is a term used in molecular biology that refers to the process of deliberately introducing foreign genetic material (DNA, RNA or artificial gene constructs) into cells. This is typically done using chemical or physical methods, such as lipofection or electroporation. Transfection is widely used in research and medical settings for various purposes, including studying gene function, producing proteins, developing gene therapies, and creating genetically modified organisms. It's important to note that transfection is different from transduction, which is the process of introducing genetic material into cells using viruses as vectors.

The cell nucleus is a membrane-bound organelle found in the eukaryotic cells (cells with a true nucleus). It contains most of the cell's genetic material, organized as DNA molecules in complex with proteins, RNA molecules, and histones to form chromosomes.

The primary function of the cell nucleus is to regulate and control the activities of the cell, including growth, metabolism, protein synthesis, and reproduction. It also plays a crucial role in the process of mitosis (cell division) by separating and protecting the genetic material during this process. The nuclear membrane, or nuclear envelope, surrounding the nucleus is composed of two lipid bilayers with numerous pores that allow for the selective transport of molecules between the nucleoplasm (nucleus interior) and the cytoplasm (cell exterior).

The cell nucleus is a vital structure in eukaryotic cells, and its dysfunction can lead to various diseases, including cancer and genetic disorders.

Progesterone congeners refer to synthetic or naturally occurring compounds that are structurally similar to progesterone, a steroid hormone involved in the menstrual cycle, pregnancy, and embryogenesis. These compounds have similar chemical structures to progesterone and may exhibit similar physiological activities, although they can also have unique properties and uses. Examples of progesterone congeners include various synthetic progestins used in hormonal contraceptives and other medical treatments.

Genistein is defined as a type of isoflavone, which is a plant-derived compound with estrogen-like properties. It is found in soybeans and other legumes. Genistein acts as a phytoestrogen, meaning it can bind to estrogen receptors and have both weak estrogenic and anti-estrogenic effects in the body.

In addition to its estrogenic activity, genistein has been found to have various biological activities, such as antioxidant, anti-inflammatory, and anticancer properties. It has been studied for its potential role in preventing or treating a variety of health conditions, including cancer, cardiovascular disease, osteoporosis, and menopausal symptoms. However, more research is needed to fully understand the potential benefits and risks of genistein supplementation.

A base sequence in the context of molecular biology refers to the specific order of nucleotides in a DNA or RNA molecule. In DNA, these nucleotides are adenine (A), guanine (G), cytosine (C), and thymine (T). In RNA, uracil (U) takes the place of thymine. The base sequence contains genetic information that is transcribed into RNA and ultimately translated into proteins. It is the exact order of these bases that determines the genetic code and thus the function of the DNA or RNA molecule.

Triazoles are a class of antifungal medications that have broad-spectrum activity against various fungi, including yeasts, molds, and dermatophytes. They work by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased permeability and disruption of fungal growth. Triazoles are commonly used in both systemic and topical formulations for the treatment of various fungal infections, such as candidiasis, aspergillosis, cryptococcosis, and dermatophytoses. Some examples of triazole antifungals include fluconazole, itraconazole, voriconazole, and posaconazole.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Orchiectomy is a surgical procedure where one or both of the testicles are removed. It is also known as castration. This procedure can be performed for various reasons, including the treatment of testicular cancer, prostate cancer, or other conditions that may affect the testicles. It can also be done to reduce levels of male hormones in the body, such as in the case of transgender women undergoing gender affirming surgery. The specific medical definition may vary slightly depending on the context and the extent of the procedure.

Luteinizing Hormone (LH) is a glycoprotein hormone, which is primarily produced and released by the anterior pituitary gland. In women, a surge of LH triggers ovulation, the release of an egg from the ovaries during the menstrual cycle. During pregnancy, LH stimulates the corpus luteum to produce progesterone. In men, LH stimulates the testes to produce testosterone. It plays a crucial role in sexual development, reproduction, and maintaining the reproductive system.

Protein binding, in the context of medical and biological sciences, refers to the interaction between a protein and another molecule (known as the ligand) that results in a stable complex. This process is often reversible and can be influenced by various factors such as pH, temperature, and concentration of the involved molecules.

In clinical chemistry, protein binding is particularly important when it comes to drugs, as many of them bind to proteins (especially albumin) in the bloodstream. The degree of protein binding can affect a drug's distribution, metabolism, and excretion, which in turn influence its therapeutic effectiveness and potential side effects.

Protein-bound drugs may be less available for interaction with their target tissues, as only the unbound or "free" fraction of the drug is active. Therefore, understanding protein binding can help optimize dosing regimens and minimize adverse reactions.

Nuclear Receptor Coactivator 1 (NCOA1), also known as Steroid Receptor Coactivator-1 (SRC-1), is a protein that functions as a transcriptional coactivator. It plays an essential role in the regulation of gene expression by interacting with various nuclear receptors, such as estrogen receptor, androgen receptor, glucocorticoid receptor, and thyroid hormone receptor. NCOA1 contains several functional domains that enable it to bind to these nuclear receptors and recruit other coregulatory proteins, including histone modifiers and chromatin remodeling factors, to form a large transcriptional activation complex. This results in the modification of chromatin structure and the recruitment of RNA polymerase II, leading to the initiation of transcription of target genes. NCOA1 has been implicated in various physiological processes, including development, differentiation, metabolism, and reproduction, as well as in several pathological conditions, such as cancer and metabolic disorders.

Sulfotransferases (STs) are a group of enzymes that play a crucial role in the process of sulfoconjugation, which is the transfer of a sulfo group (-SO3H) from a donor molecule to an acceptor molecule. These enzymes are widely distributed in nature and are found in various organisms, including humans.

In humans, STs are involved in the metabolism and detoxification of numerous xenobiotics, such as drugs, food additives, and environmental pollutants, as well as endogenous compounds, such as hormones, neurotransmitters, and lipids. The sulfoconjugation reaction catalyzed by STs can increase the water solubility of these compounds, facilitating their excretion from the body.

STs can be classified into several families based on their sequence similarity and cofactor specificity. The largest family of STs is the cytosolic sulfotransferases, which use 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a cofactor to transfer the sulfo group to various acceptor molecules, including phenols, alcohols, amines, and steroids.

Abnormalities in ST activity have been implicated in several diseases, such as cancer, cardiovascular disease, and neurological disorders. Therefore, understanding the function and regulation of STs is essential for developing new therapeutic strategies to treat these conditions.

A "knockout" mouse is a genetically engineered mouse in which one or more genes have been deleted or "knocked out" using molecular biology techniques. This allows researchers to study the function of specific genes and their role in various biological processes, as well as potential associations with human diseases. The mice are generated by introducing targeted DNA modifications into embryonic stem cells, which are then used to create a live animal. Knockout mice have been widely used in biomedical research to investigate gene function, disease mechanisms, and potential therapeutic targets.

Carcinoma, ductal, breast is a type of breast cancer that begins in the milk ducts (the tubes that carry milk from the lobules of the breast to the nipple). It is called "ductal" because it starts in the cells that line the milk ducts. Ductal carcinoma can be further classified as either non-invasive or invasive, based on whether the cancer cells are confined to the ducts or have spread beyond them into the surrounding breast tissue.

Non-invasive ductal carcinoma (also known as intraductal carcinoma or ductal carcinoma in situ) is a condition where abnormal cells have been found in the lining of the milk ducts, but they have not spread outside of the ducts. These cells have the potential to become invasive and spread to other parts of the breast or body if left untreated.

Invasive ductal carcinoma (IDC) is a type of breast cancer that starts in a milk duct and then grows into the surrounding breast tissue. From there, it can spread to other parts of the body through the bloodstream and lymphatic system. IDC is the most common form of breast cancer, accounting for about 80% of all cases.

Symptoms of ductal carcinoma may include a lump or thickening in the breast, changes in the size or shape of the breast, dimpling or puckering of the skin on the breast, nipple discharge (especially if it is clear or bloody), and/or redness or scaling of the nipple or breast skin. However, many cases of ductal carcinoma are detected through mammography before any symptoms develop.

Treatment for ductal carcinoma depends on several factors, including the stage and grade of the cancer, as well as the patient's overall health and personal preferences. Treatment options may include surgery (such as a lumpectomy or mastectomy), radiation therapy, chemotherapy, hormone therapy, and/or targeted therapies.

Coumestrol is a type of phytoestrogen, which is a plant-derived compound that can mimic the effects of estrogen in the body. It belongs to a class of compounds called coumestans and is found in various plants such as clover, alfalfa, and soybeans. Coumestrol has weak estrogenic activity and can bind to estrogen receptors in the body, potentially affecting hormonal balance and having both estrogenic and anti-estrogenic effects. It has been studied for its potential effects on various health conditions, including cancer, osteoporosis, and cardiovascular disease.

Receptor cross-talk, also known as receptor crosstalk or cross-communication, refers to the phenomenon where two or more receptors in a cell interact with each other and modulate their signals in a coordinated manner. This interaction can occur at various levels, such as sharing downstream signaling pathways, physically interacting with each other, or influencing each other's expression or activity.

In the context of G protein-coupled receptors (GPCRs), which are a large family of membrane receptors that play crucial roles in various physiological processes, cross-talk can occur between different GPCRs or between GPCRs and other types of receptors. For example, one GPCR may activate a signaling pathway that inhibits the activity of another GPCR, leading to complex regulatory mechanisms that allow cells to fine-tune their responses to various stimuli.

Receptor cross-talk can have important implications for drug development and therapy, as it can affect the efficacy and safety of drugs that target specific receptors. Understanding the mechanisms of receptor cross-talk can help researchers design more effective and targeted therapies for a wide range of diseases.

Molecular sequence data refers to the specific arrangement of molecules, most commonly nucleotides in DNA or RNA, or amino acids in proteins, that make up a biological macromolecule. This data is generated through laboratory techniques such as sequencing, and provides information about the exact order of the constituent molecules. This data is crucial in various fields of biology, including genetics, evolution, and molecular biology, allowing for comparisons between different organisms, identification of genetic variations, and studies of gene function and regulation.

Equilin is a type of hormone that belongs to the class of estrogens. It is a natural component found in the body, specifically in women, and it plays a role in the development and maintenance of female sexual characteristics. Equilin is formed from the metabolism of another estrogen called estrone. It has both estrogenic and anti-estrogenic properties, meaning that it can both stimulate and inhibit estrogenic activity in the body.

In a medical context, equilin may be used as a component in some hormone replacement therapies (HRT) for postmenopausal women. It is often combined with other hormones, such as estradiol and/or progestins, to create a more balanced HRT regimen that can help alleviate symptoms of menopause while also providing protection against osteoporosis and other conditions associated with low estrogen levels.

It's important to note that the use of hormone replacement therapy carries certain risks, including an increased risk of breast cancer, heart disease, and stroke, so it should only be used under the close supervision of a healthcare provider.

Nuclear Receptor Coactivator 3 (NCOA3), also known as AIB1 (Amplified in Breast Cancer 1), is a protein that functions as a coactivator for several nuclear receptors. Nuclear receptors are transcription factors that regulate gene expression in response to various signals, such as hormones and vitamins.

NCOA3/AIB1 contains several functional domains, including an N-terminal basic helix-loop-helix Per-Arnt-Sim (bHLH-PAS) domain, two nuclear receptor interaction motifs, and a C-terminal activation domain. These domains enable NCOA3/AIB1 to interact with various nuclear receptors, recruit additional coactivators, and stimulate transcription of target genes.

NCOA3/AIB1 has been implicated in the development and progression of several types of cancer, including breast, prostate, and ovarian cancers. Amplification or overexpression of NCOA3/AIB1 has been observed in these cancers, leading to increased cell growth, survival, and metastasis. Additionally, NCOA3/AIB1 has been linked to endocrine resistance in breast cancer, making it a potential target for therapeutic intervention.

Transcription factors are proteins that play a crucial role in regulating gene expression by controlling the transcription of DNA to messenger RNA (mRNA). They function by binding to specific DNA sequences, known as response elements, located in the promoter region or enhancer regions of target genes. This binding can either activate or repress the initiation of transcription, depending on the properties and interactions of the particular transcription factor. Transcription factors often act as part of a complex network of regulatory proteins that determine the precise spatiotemporal patterns of gene expression during development, differentiation, and homeostasis in an organism.

Feminization is a process or condition in which typically male characteristics are diminished or absent, and female characteristics become more prominent. This term is often used in the context of transgender health to describe hormone therapy that helps individuals align their physical appearance with their gender identity. The goal of feminizing hormone therapy is to promote the development of secondary sexual characteristics such as breast development, softer skin, reduced muscle mass and body hair, and fat redistribution to create a more typically female body shape. It's important to note that every individual's experience with feminization is unique, and the specific changes experienced may vary depending on factors such as age, genetics, and the duration of hormone therapy.

Androstenedione is a steroid hormone produced by the adrenal glands, ovaries, and testes. It is a precursor to both male and female sex hormones, including testosterone and estrogen. In the adrenal glands, it is produced from cholesterol through a series of biochemical reactions involving several enzymes. Androstenedione can also be converted into other steroid hormones, such as dehydroepiandrosterone (DHEA) and estrone.

In the body, androstenedione plays an important role in the development and maintenance of secondary sexual characteristics, such as facial hair and a deep voice in men, and breast development and menstrual cycles in women. It also contributes to bone density, muscle mass, and overall physical strength.

Androstenedione is available as a dietary supplement and has been marketed as a way to boost athletic performance and increase muscle mass. However, its effectiveness for these purposes is not supported by scientific evidence, and it may have harmful side effects when taken in high doses or for extended periods of time. Additionally, the use of androstenedione as a dietary supplement is banned by many sports organizations, including the International Olympic Committee and the National Collegiate Athletic Association.

Tumor markers are substances that can be found in the body and their presence can indicate the presence of certain types of cancer or other conditions. Biological tumor markers refer to those substances that are produced by cancer cells or by other cells in response to cancer or certain benign (non-cancerous) conditions. These markers can be found in various bodily fluids such as blood, urine, or tissue samples.

Examples of biological tumor markers include:

1. Proteins: Some tumor markers are proteins that are produced by cancer cells or by other cells in response to the presence of cancer. For example, prostate-specific antigen (PSA) is a protein produced by normal prostate cells and in higher amounts by prostate cancer cells.
2. Genetic material: Tumor markers can also include genetic material such as DNA, RNA, or microRNA that are shed by cancer cells into bodily fluids. For example, circulating tumor DNA (ctDNA) is genetic material from cancer cells that can be found in the bloodstream.
3. Metabolites: Tumor markers can also include metabolic products produced by cancer cells or by other cells in response to cancer. For example, lactate dehydrogenase (LDH) is an enzyme that is released into the bloodstream when cancer cells break down glucose for energy.

It's important to note that tumor markers are not specific to cancer and can be elevated in non-cancerous conditions as well. Therefore, they should not be used alone to diagnose cancer but rather as a tool in conjunction with other diagnostic tests and clinical evaluations.

Dydrogesterone is a synthetic form of the natural hormone progesterone, which is used in various forms of medical therapy. It is primarily used as a hormonal supplement during infertility treatments and to prevent pregnancy loss in women with a history of miscarriage due to progesterone deficiency.

Dydrogesterone works by mimicking the effects of natural progesterone, which helps to prepare the lining of the uterus for implantation of a fertilized egg and supports the early stages of pregnancy. It is also used in the treatment of endometriosis, a condition where tissue similar to the lining of the uterus grows outside of it, causing pain and other symptoms.

Dydrogesterone is available in various forms, including tablets and capsules, and is typically taken orally. The dosage and duration of treatment may vary depending on the specific medical condition being treated and the individual patient's needs. As with any medication, dydrogesterone should only be used under the guidance and supervision of a qualified healthcare provider.

G-protein-coupled receptors (GPCRs) are a family of membrane receptors that play an essential role in cellular signaling and communication. These receptors possess seven transmembrane domains, forming a structure that spans the lipid bilayer of the cell membrane. They are called "G-protein-coupled" because they interact with heterotrimeric G proteins upon activation, which in turn modulate various downstream signaling pathways.

When an extracellular ligand binds to a GPCR, it causes a conformational change in the receptor's structure, leading to the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) on the associated G protein's α subunit. This exchange triggers the dissociation of the G protein into its α and βγ subunits, which then interact with various effector proteins to elicit cellular responses.

There are four main families of GPCRs, classified based on their sequence similarities and downstream signaling pathways:

1. Gq-coupled receptors: These receptors activate phospholipase C (PLC), which leads to the production of inositol trisphosphate (IP3) and diacylglycerol (DAG). IP3 induces calcium release from intracellular stores, while DAG activates protein kinase C (PKC).
2. Gs-coupled receptors: These receptors activate adenylyl cyclase, which increases the production of cyclic adenosine monophosphate (cAMP) and subsequently activates protein kinase A (PKA).
3. Gi/o-coupled receptors: These receptors inhibit adenylyl cyclase, reducing cAMP levels and modulating PKA activity. Additionally, they can activate ion channels or regulate other signaling pathways through the βγ subunits.
4. G12/13-coupled receptors: These receptors primarily activate RhoGEFs, which in turn activate RhoA and modulate cytoskeletal organization and cellular motility.

GPCRs are involved in various physiological processes, including neurotransmission, hormone signaling, immune response, and sensory perception. Dysregulation of GPCR function has been implicated in numerous diseases, making them attractive targets for drug development.

Stearyl-sulfatase is a type of enzyme that is responsible for breaking down certain types of fatty substances called lipids in the body. Specifically, it helps to break down a substance called stearyl sulfate, which is a type of sulfated lipid.

Stearyl-sulfatase is found in various tissues throughout the body, including the brain, skin, and kidneys. Mutations in the gene that provides instructions for making this enzyme can lead to a condition called X-linked ichthyosis, which is characterized by dry, scaly skin. This is because the body is unable to properly break down stearyl sulfate and other related lipids, leading to their accumulation in the skin.

In medical terminology, steruly-sulfatase may also be referred to as arylsulfatase C or Arylsulfatase-C.

The pituitary gland is a small, endocrine gland located at the base of the brain, in the sella turcica of the sphenoid bone. It is often called the "master gland" because it controls other glands and makes the hormones that trigger many body functions. The pituitary gland measures about 0.5 cm in height and 1 cm in width, and it weighs approximately 0.5 grams.

The pituitary gland is divided into two main parts: the anterior lobe (adenohypophysis) and the posterior lobe (neurohypophysis). The anterior lobe is further divided into three zones: the pars distalis, pars intermedia, and pars tuberalis. Each part of the pituitary gland has distinct functions and produces different hormones.

The anterior pituitary gland produces and releases several important hormones, including:

* Growth hormone (GH), which regulates growth and development in children and helps maintain muscle mass and bone strength in adults.
* Thyroid-stimulating hormone (TSH), which controls the production of thyroid hormones by the thyroid gland.
* Adrenocorticotropic hormone (ACTH), which stimulates the adrenal glands to produce cortisol and other steroid hormones.
* Follicle-stimulating hormone (FSH) and luteinizing hormone (LH), which regulate reproductive function in both males and females.
* Prolactin, which stimulates milk production in pregnant and lactating women.

The posterior pituitary gland stores and releases two hormones that are produced by the hypothalamus:

* Antidiuretic hormone (ADH), which helps regulate water balance in the body by controlling urine production.
* Oxytocin, which stimulates uterine contractions during childbirth and milk release during breastfeeding.

Overall, the pituitary gland plays a critical role in maintaining homeostasis and regulating various bodily functions, including growth, development, metabolism, and reproductive function.

Catechol-O-methyltransferase (COMT) is an enzyme that plays a role in the metabolism of catecholamines, which are neurotransmitters and hormones such as dopamine, norepinephrine, and epinephrine. COMT mediates the transfer of a methyl group from S-adenosylmethionine (SAM) to a catechol functional group in these molecules, resulting in the formation of methylated products that are subsequently excreted.

The methylation of catecholamines by COMT regulates their concentration and activity in the body, and genetic variations in the COMT gene can affect enzyme function and contribute to individual differences in the metabolism of these neurotransmitters. This has been implicated in various neurological and psychiatric conditions, including Parkinson's disease, schizophrenia, and attention deficit hyperactivity disorder (ADHD).

Cytosol refers to the liquid portion of the cytoplasm found within a eukaryotic cell, excluding the organelles and structures suspended in it. It is the site of various metabolic activities and contains a variety of ions, small molecules, and enzymes. The cytosol is where many biochemical reactions take place, including glycolysis, protein synthesis, and the regulation of cellular pH. It is also where some organelles, such as ribosomes and vesicles, are located. In contrast to the cytosol, the term "cytoplasm" refers to the entire contents of a cell, including both the cytosol and the organelles suspended within it.

Dehydroepiandrosterone (DHEA) is a steroid hormone produced by the adrenal glands. It serves as a precursor to other hormones, including androgens such as testosterone and estrogens such as estradiol. DHEA levels typically peak during early adulthood and then gradually decline with age.

DHEA has been studied for its potential effects on various health conditions, including aging, cognitive function, sexual dysfunction, and certain chronic diseases. However, the evidence supporting its use for these purposes is generally limited and inconclusive. As with any supplement or medication, it's important to consult with a healthcare provider before taking DHEA to ensure safety and effectiveness.

Promegestone is a synthetic progestin, which is a type of hormone that is similar to the natural progesterone produced in the human body. It is used primarily as a component of hormonal contraceptives and for the treatment of various conditions related to hormonal imbalances.

In medical terms, promegestone can be defined as:

A synthetic progestin with glucocorticoid activity, used in the treatment of endometriosis, mastodynia (breast pain), and uterine fibroids. It is also used as a component of hormonal contraceptives to prevent pregnancy. Promegestone works by binding to progesterone receptors in the body, which helps regulate the menstrual cycle and prevent ovulation.

It's important to note that promegestone should only be used under the supervision of a healthcare provider, as it can have side effects and may interact with other medications.

Nuclear Receptor Coactivator 2 (NCoA-2, also known as SRC-2 or TIF2) is a protein that functions as a transcriptional coactivator. It plays an essential role in the regulation of gene expression by interacting with nuclear receptors, which are transcription factors that bind to specific DNA sequences and control the expression of target genes.

NCoA-2 contains several functional domains, including an intrinsic histone acetyltransferase (HAT) domain, which can acetylate histone proteins and modify chromatin structure, leading to the activation of gene transcription. NCoA-2 also has a bromodomain, which recognizes and binds to acetylated lysine residues on histones, further contributing to its ability to modulate chromatin structure and function.

NCoA-2 interacts with various nuclear receptors, such as the estrogen receptor (ER), glucocorticoid receptor (GR), progesterone receptor (PR), and androgen receptor (AR). By binding to these receptors, NCoA-2 enhances their transcriptional activity, ultimately influencing various physiological processes, including cell growth, differentiation, and metabolism.

Dysregulation of NCoA-2 has been implicated in several diseases, such as cancer, where its overexpression can contribute to tumor progression and hormone resistance. Therefore, understanding the molecular mechanisms underlying NCoA-2 function is crucial for developing novel therapeutic strategies targeting nuclear receptor signaling pathways.

Gene expression profiling is a laboratory technique used to measure the activity (expression) of thousands of genes at once. This technique allows researchers and clinicians to identify which genes are turned on or off in a particular cell, tissue, or organism under specific conditions, such as during health, disease, development, or in response to various treatments.

The process typically involves isolating RNA from the cells or tissues of interest, converting it into complementary DNA (cDNA), and then using microarray or high-throughput sequencing technologies to determine which genes are expressed and at what levels. The resulting data can be used to identify patterns of gene expression that are associated with specific biological states or processes, providing valuable insights into the underlying molecular mechanisms of diseases and potential targets for therapeutic intervention.

In recent years, gene expression profiling has become an essential tool in various fields, including cancer research, drug discovery, and personalized medicine, where it is used to identify biomarkers of disease, predict patient outcomes, and guide treatment decisions.

Steroids, also known as corticosteroids, are a type of hormone that the adrenal gland produces in your body. They have many functions, such as controlling the balance of salt and water in your body and helping to reduce inflammation. Steroids can also be synthetically produced and used as medications to treat a variety of conditions, including allergies, asthma, skin conditions, and autoimmune disorders.

Steroid medications are available in various forms, such as oral pills, injections, creams, and inhalers. They work by mimicking the effects of natural hormones produced by your body, reducing inflammation and suppressing the immune system's response to prevent or reduce symptoms. However, long-term use of steroids can have significant side effects, including weight gain, high blood pressure, osteoporosis, and increased risk of infections.

It is important to note that anabolic steroids are a different class of drugs that are sometimes abused for their muscle-building properties. These steroids are synthetic versions of the male hormone testosterone and can have serious health consequences when taken in large doses or without medical supervision.

The preoptic area (POA) is a region within the anterior hypothalamus of the brain. It is named for its location near the optic chiasm, where the optic nerves cross. The preoptic area is involved in various functions, including body temperature regulation, sexual behavior, and sleep-wake regulation.

The preoptic area contains several groups of neurons that are sensitive to changes in temperature and are responsible for generating heat through shivering or non-shivering thermogenesis. It also contains neurons that release inhibitory neurotransmitters such as GABA and galanin, which help regulate arousal and sleep.

Additionally, the preoptic area has been implicated in the regulation of sexual behavior, particularly in males. Certain populations of neurons within the preoptic area are involved in the expression of male sexual behavior, such as mounting and intromission.

Overall, the preoptic area is a critical region for the regulation of various physiological and behavioral functions, making it an important area of study in neuroscience research.

Follicle-Stimulating Hormone (FSH) is a glycoprotein hormone secreted and released by the anterior pituitary gland. In females, it promotes the growth and development of ovarian follicles in the ovary, which ultimately leads to the maturation and release of an egg (ovulation). In males, FSH stimulates the testes to produce sperm. It works in conjunction with luteinizing hormone (LH) to regulate reproductive processes. The secretion of FSH is controlled by the hypothalamic-pituitary-gonadal axis and its release is influenced by the levels of gonadotropin-releasing hormone (GnRH), estrogen, inhibin, and androgens.

The medical definition of 'charcoal' is referred to as activated charcoal, which is a fine, black powder made from coconut shells, wood, or other natural substances. It is used in medical situations to absorb poison or drugs in the stomach, thereby preventing their absorption into the body and reducing their toxic effects. Activated charcoal works by binding to certain chemicals and preventing them from being absorbed through the digestive tract.

Activated charcoal is generally safe for most people when taken as directed, but it can cause side effects such as black stools, constipation, and regurgitation of the charcoal. It should be used under medical supervision and not as a substitute for seeking immediate medical attention in case of poisoning or overdose.

It's important to note that activated charcoal is different from regular charcoal, which is not safe to consume and can contain harmful chemicals or substances.

Uterine neoplasms refer to abnormal growths in the uterus, which can be benign (non-cancerous) or malignant (cancerous). These growths can originate from different types of cells within the uterus, leading to various types of uterine neoplasms. The two main categories of uterine neoplasms are endometrial neoplasms and uterine sarcomas.

Endometrial neoplasms develop from the endometrium, which is the inner lining of the uterus. Most endometrial neoplasms are classified as endometrioid adenocarcinomas, arising from glandular cells in the endometrium. Other types include serous carcinoma, clear cell carcinoma, and mucinous carcinoma.

Uterine sarcomas, on the other hand, are less common and originate from the connective tissue (stroma) or muscle (myometrium) of the uterus. Uterine sarcomas can be further divided into several subtypes, such as leiomyosarcoma, endometrial stromal sarcoma, and undifferentiated uterine sarcoma.

Uterine neoplasms can cause various symptoms, including abnormal vaginal bleeding or discharge, pelvic pain, and difficulty urinating or having bowel movements. The diagnosis typically involves a combination of imaging tests (such as ultrasound, CT, or MRI scans) and tissue biopsies to determine the type and extent of the neoplasm. Treatment options depend on the type, stage, and patient's overall health but may include surgery, radiation therapy, chemotherapy, or hormone therapy.

Hormones are defined as chemical messengers that are produced by endocrine glands or specialized cells and are transported through the bloodstream to tissues and organs, where they elicit specific responses. They play crucial roles in regulating various physiological processes such as growth, development, metabolism, reproduction, and mood. Examples of hormones include insulin, estrogen, testosterone, adrenaline, and thyroxine.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Fadrozole is a non-steroidal aromatase inhibitor drug that is used in the treatment of breast cancer. Aromatase inhibitors work by blocking the production of estrogen, which some types of breast cancer cells need to grow. By reducing the amount of estrogen in the body, fadrozole can help slow or stop the growth of these cancer cells.

Fadrozole is typically used as a treatment for postmenopausal women with hormone receptor-positive breast cancer. It may be used as a first-line therapy or after other treatments have failed. The drug is administered orally, and the typical dosage is 1-2 mg per day.

Like all medications, fadrozole can cause side effects, including hot flashes, nausea, vomiting, and joint pain. In some cases, it may also cause more serious side effects such as liver damage or an increased risk of bone fractures. Patients taking fadrozole should be monitored closely by their healthcare provider to ensure that the drug is working effectively and to manage any side effects that may occur.

In the context of medical and biological sciences, a "binding site" refers to a specific location on a protein, molecule, or cell where another molecule can attach or bind. This binding interaction can lead to various functional changes in the original protein or molecule. The other molecule that binds to the binding site is often referred to as a ligand, which can be a small molecule, ion, or even another protein.

The binding between a ligand and its target binding site can be specific and selective, meaning that only certain ligands can bind to particular binding sites with high affinity. This specificity plays a crucial role in various biological processes, such as signal transduction, enzyme catalysis, or drug action.

In the case of drug development, understanding the location and properties of binding sites on target proteins is essential for designing drugs that can selectively bind to these sites and modulate protein function. This knowledge can help create more effective and safer therapeutic options for various diseases.

Up-regulation is a term used in molecular biology and medicine to describe an increase in the expression or activity of a gene, protein, or receptor in response to a stimulus. This can occur through various mechanisms such as increased transcription, translation, or reduced degradation of the molecule. Up-regulation can have important functional consequences, for example, enhancing the sensitivity or response of a cell to a hormone, neurotransmitter, or drug. It is a normal physiological process that can also be induced by disease or pharmacological interventions.

"Bone" is the hard, dense connective tissue that makes up the skeleton of vertebrate animals. It provides support and protection for the body's internal organs, and serves as a attachment site for muscles, tendons, and ligaments. Bone is composed of cells called osteoblasts and osteoclasts, which are responsible for bone formation and resorption, respectively, and an extracellular matrix made up of collagen fibers and mineral crystals.

Bones can be classified into two main types: compact bone and spongy bone. Compact bone is dense and hard, and makes up the outer layer of all bones and the shafts of long bones. Spongy bone is less dense and contains large spaces, and makes up the ends of long bones and the interior of flat and irregular bones.

The human body has 206 bones in total. They can be further classified into five categories based on their shape: long bones, short bones, flat bones, irregular bones, and sesamoid bones.

Deoxyribonucleic acid (DNA) is the genetic material present in the cells of organisms where it is responsible for the storage and transmission of hereditary information. DNA is a long molecule that consists of two strands coiled together to form a double helix. Each strand is made up of a series of four nucleotide bases - adenine (A), guanine (G), cytosine (C), and thymine (T) - that are linked together by phosphate and sugar groups. The sequence of these bases along the length of the molecule encodes genetic information, with A always pairing with T and C always pairing with G. This base-pairing allows for the replication and transcription of DNA, which are essential processes in the functioning and reproduction of all living organisms.

Aging is a complex, progressive and inevitable process of bodily changes over time, characterized by the accumulation of cellular damage and degenerative changes that eventually lead to increased vulnerability to disease and death. It involves various biological, genetic, environmental, and lifestyle factors that contribute to the decline in physical and mental functions. The medical field studies aging through the discipline of gerontology, which aims to understand the underlying mechanisms of aging and develop interventions to promote healthy aging and extend the human healthspan.

The vagina is the canal that joins the cervix (the lower part of the uterus) to the outside of the body. It also is known as the birth canal because babies pass through it during childbirth. The vagina is where sexual intercourse occurs and where menstrual blood exits the body. It has a flexible wall that can expand and retract. During sexual arousal, the vaginal walls swell with blood to become more elastic in order to accommodate penetration.

It's important to note that sometimes people use the term "vagina" to refer to the entire female genital area, including the external structures like the labia and clitoris. But technically, these are considered part of the vulva, not the vagina.

Bone density refers to the amount of bone mineral content (usually measured in grams) in a given volume of bone (usually measured in cubic centimeters). It is often used as an indicator of bone strength and fracture risk. Bone density is typically measured using dual-energy X-ray absorptiometry (DXA) scans, which provide a T-score that compares the patient's bone density to that of a young adult reference population. A T-score of -1 or above is considered normal, while a T-score between -1 and -2.5 indicates osteopenia (low bone mass), and a T-score below -2.5 indicates osteoporosis (porous bones). Regular exercise, adequate calcium and vitamin D intake, and medication (if necessary) can help maintain or improve bone density and prevent fractures.

The hypothalamus is a small, vital region of the brain that lies just below the thalamus and forms part of the limbic system. It plays a crucial role in many important functions including:

1. Regulation of body temperature, hunger, thirst, fatigue, sleep, and circadian rhythms.
2. Production and regulation of hormones through its connection with the pituitary gland (the hypophysis). It controls the release of various hormones by producing releasing and inhibiting factors that regulate the anterior pituitary's function.
3. Emotional responses, behavior, and memory formation through its connections with the limbic system structures like the amygdala and hippocampus.
4. Autonomic nervous system regulation, which controls involuntary physiological functions such as heart rate, blood pressure, and digestion.
5. Regulation of the immune system by interacting with the autonomic nervous system.

Damage to the hypothalamus can lead to various disorders like diabetes insipidus, growth hormone deficiency, altered temperature regulation, sleep disturbances, and emotional or behavioral changes.

Estrus is a term used in veterinary medicine to describe the physiological and behavioral state of female mammals that are ready to mate and conceive. It refers to the period of time when the female's reproductive system is most receptive to fertilization.

During estrus, the female's ovaries release one or more mature eggs (ovulation) into the fallopian tubes, where they can be fertilized by sperm from a male. This phase of the estrous cycle is often accompanied by changes in behavior and physical appearance, such as increased vocalization, restlessness, and swelling of the genital area.

The duration and frequency of estrus vary widely among different species of mammals. In some animals, such as dogs and cats, estrus occurs regularly at intervals of several weeks or months, while in others, such as cows and mares, it may only occur once or twice a year.

It's important to note that the term "estrus" is not used to describe human reproductive physiology. In humans, the equivalent phase of the menstrual cycle is called ovulation.

Osteoporosis is a systemic skeletal disease characterized by low bone mass, deterioration of bone tissue, and disruption of bone architecture, leading to increased risk of fractures, particularly in the spine, wrist, and hip. It mainly affects older people, especially postmenopausal women, due to hormonal changes that reduce bone density. Osteoporosis can also be caused by certain medications, medical conditions, or lifestyle factors such as smoking, alcohol abuse, and a lack of calcium and vitamin D in the diet. The diagnosis is often made using bone mineral density testing, and treatment may include medication to slow bone loss, promote bone formation, and prevent fractures.

Neuroprotective agents are substances that protect neurons or nerve cells from damage, degeneration, or death caused by various factors such as trauma, inflammation, oxidative stress, or excitotoxicity. These agents work through different mechanisms, including reducing the production of free radicals, inhibiting the release of glutamate (a neurotransmitter that can cause cell damage in high concentrations), promoting the growth and survival of neurons, and preventing apoptosis (programmed cell death). Neuroprotective agents have been studied for their potential to treat various neurological disorders, including stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, and multiple sclerosis. However, more research is needed to fully understand their mechanisms of action and to develop effective therapies.

Sex Hormone-Binding Globulin (SHBG) is a protein produced mainly in the liver that plays a crucial role in regulating the active forms of the sex hormones, testosterone and estradiol, in the body. SHBG binds to these hormones in the bloodstream, creating a reservoir of bound hormones. Only the unbound (or "free") fraction of testosterone and estradiol is considered biologically active and can easily enter cells to exert its effects.

By binding to sex hormones, SHBG helps control their availability and transport in the body. Factors such as age, sex, infection with certain viruses (like hepatitis or HIV), liver disease, obesity, and various medications can influence SHBG levels and, consequently, impact the amount of free testosterone and estradiol in circulation.

SHBG is an essential factor in maintaining hormonal balance and has implications for several physiological processes, including sexual development, reproduction, bone health, muscle mass, and overall well-being. Abnormal SHBG levels can contribute to various medical conditions, such as hypogonadism (low testosterone levels), polycystic ovary syndrome (PCOS), and certain types of cancer.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Propionates, in a medical context, most commonly refer to a group of medications that are used as topical creams or gels to treat fungal infections of the skin. Propionic acid and its salts, such as propionate, are the active ingredients in these medications. They work by inhibiting the growth of fungi, which causes the infection. Common examples of propionate-containing medications include creams used to treat athlete's foot, ringworm, and jock itch.

It is important to note that there are many different types of medications and compounds that contain the word "propionate" in their name, as it refers to a specific chemical structure. However, in a medical context, it most commonly refers to antifungal creams or gels.

The testis, also known as the testicle, is a male reproductive organ that is part of the endocrine system. It is located in the scrotum, outside of the abdominal cavity. The main function of the testis is to produce sperm and testosterone, the primary male sex hormone.

The testis is composed of many tiny tubules called seminiferous tubules, where sperm are produced. These tubules are surrounded by a network of blood vessels, nerves, and supportive tissues. The sperm then travel through a series of ducts to the epididymis, where they mature and become capable of fertilization.

Testosterone is produced in the Leydig cells, which are located in the interstitial tissue between the seminiferous tubules. Testosterone plays a crucial role in the development and maintenance of male secondary sexual characteristics, such as facial hair, deep voice, and muscle mass. It also supports sperm production and sexual function.

Abnormalities in testicular function can lead to infertility, hormonal imbalances, and other health problems. Regular self-examinations and medical check-ups are recommended for early detection and treatment of any potential issues.

Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.

Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.

"Cutaneous administration" is a route of administering medication or treatment through the skin. This can be done through various methods such as:

1. Topical application: This involves applying the medication directly to the skin in the form of creams, ointments, gels, lotions, patches, or solutions. The medication is absorbed into the skin and enters the systemic circulation slowly over a period of time. Topical medications are often used for local effects, such as treating eczema, psoriasis, or fungal infections.

2. Iontophoresis: This method uses a mild electrical current to help a medication penetrate deeper into the skin. A positive charge is applied to a medication with a negative charge, or vice versa, causing it to be attracted through the skin. Iontophoresis is often used for local pain management and treating conditions like hyperhidrosis (excessive sweating).

3. Transdermal delivery systems: These are specialized patches that contain medication within them. The patch is applied to the skin, and as time passes, the medication is released through the skin and into the systemic circulation. This method allows for a steady, controlled release of medication over an extended period. Common examples include nicotine patches for smoking cessation and hormone replacement therapy patches.

Cutaneous administration offers several advantages, such as avoiding first-pass metabolism (which can reduce the effectiveness of oral medications), providing localized treatment, and allowing for self-administration in some cases. However, it may not be suitable for all types of medications or conditions, and potential side effects include skin irritation, allergic reactions, and systemic absorption leading to unwanted systemic effects.

A "reporter gene" is a type of gene that is linked to a gene of interest in order to make the expression or activity of that gene detectable. The reporter gene encodes for a protein that can be easily measured and serves as an indicator of the presence and activity of the gene of interest. Commonly used reporter genes include those that encode for fluorescent proteins, enzymes that catalyze colorimetric reactions, or proteins that bind to specific molecules.

In the context of genetics and genomics research, a reporter gene is often used in studies involving gene expression, regulation, and function. By introducing the reporter gene into an organism or cell, researchers can monitor the activity of the gene of interest in real-time or after various experimental treatments. The information obtained from these studies can help elucidate the role of specific genes in biological processes and diseases, providing valuable insights for basic research and therapeutic development.

I'm sorry for any confusion, but "Polyunsaturated Alkamides" is not a widely recognized medical term or concept. It seems to be a combination of two different terms: "polyunsaturated" which relates to fatty acid chemistry, and "alkamides" which are a type of compound found in certain plants.

1. Polyunsaturated: This term refers to fatty acids that have multiple double bonds in their carbon chain. These fatty acids are essential to the human diet and are commonly found in foods like fish, nuts, and seeds. They are often referred to as Omega-3 or Omega-6 fatty acids.

2. Alkamides: These are a type of compound found in some plants, including Echinacea species. They have been studied for their potential biological activities, such as anti-inflammatory and immunomodulatory effects.

Without more context, it's difficult to provide a precise definition or medical interpretation of "Polyunsaturated Alkamides." If you have more information about how these terms are being used together, I'd be happy to try to provide a more specific answer.

Sexual maturation is the process of physical development during puberty that leads to the ability to reproduce. This process involves the development of primary and secondary sexual characteristics, changes in hormone levels, and the acquisition of reproductive capabilities. In females, this includes the onset of menstruation and the development of breasts and hips. In males, this includes the deepening of the voice, growth of facial hair, and the production of sperm. Achieving sexual maturation is an important milestone in human development and typically occurs during adolescence.

Epithelial cells are types of cells that cover the outer surfaces of the body, line the inner surfaces of organs and glands, and form the lining of blood vessels and body cavities. They provide a protective barrier against the external environment, regulate the movement of materials between the internal and external environments, and are involved in the sense of touch, temperature, and pain. Epithelial cells can be squamous (flat and thin), cuboidal (square-shaped and of equal height), or columnar (tall and narrow) in shape and are classified based on their location and function.

Drug resistance in neoplasms (also known as cancer drug resistance) refers to the ability of cancer cells to withstand the effects of chemotherapeutic agents or medications designed to kill or inhibit the growth of cancer cells. This can occur due to various mechanisms, including changes in the cancer cell's genetic makeup, alterations in drug targets, increased activity of drug efflux pumps, and activation of survival pathways.

Drug resistance can be intrinsic (present at the beginning of treatment) or acquired (developed during the course of treatment). It is a significant challenge in cancer therapy as it often leads to reduced treatment effectiveness, disease progression, and poor patient outcomes. Strategies to overcome drug resistance include the use of combination therapies, development of new drugs that target different mechanisms, and personalized medicine approaches that consider individual patient and tumor characteristics.

Apoptosis is a programmed and controlled cell death process that occurs in multicellular organisms. It is a natural process that helps maintain tissue homeostasis by eliminating damaged, infected, or unwanted cells. During apoptosis, the cell undergoes a series of morphological changes, including cell shrinkage, chromatin condensation, and fragmentation into membrane-bound vesicles called apoptotic bodies. These bodies are then recognized and engulfed by neighboring cells or phagocytic cells, preventing an inflammatory response. Apoptosis is regulated by a complex network of intracellular signaling pathways that involve proteins such as caspases, Bcl-2 family members, and inhibitors of apoptosis (IAPs).

Oral hormonal contraceptives, also known as "birth control pills," are a type of medication that contains synthetic hormones (estrogen and/or progestin) that are taken by mouth to prevent pregnancy. They work by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

There are several different types of oral hormonal contraceptives, including combined pills that contain both estrogen and progestin, and mini-pills that only contain progestin. These medications are usually taken daily for 21 days, followed by a seven-day break during which menstruation occurs. Some newer formulations may be taken continuously with no break.

It's important to note that while oral hormonal contraceptives are highly effective at preventing pregnancy when used correctly, they do not protect against sexually transmitted infections (STIs). Therefore, it is still important to use barrier methods of protection, such as condoms, during sexual activity to reduce the risk of STIs.

As with any medication, oral hormonal contraceptives can have side effects and may not be suitable for everyone. It's important to discuss any medical conditions, allergies, or medications you are taking with your healthcare provider before starting to take oral hormonal contraceptives.

The myometrium is the middle and thickest layer of the uterine wall, composed mainly of smooth muscle cells. It is responsible for the strong contractions during labor and can also contribute to bleeding during menstruation or childbirth. The myometrium is able to stretch and expand to accommodate a growing fetus and then contract during labor to help push the baby out. It also plays a role in maintaining the structure and shape of the uterus, and in protecting the internal organs within the pelvic cavity.

In the context of medicine and pharmacology, "kinetics" refers to the study of how a drug moves throughout the body, including its absorption, distribution, metabolism, and excretion (often abbreviated as ADME). This field is called "pharmacokinetics."

1. Absorption: This is the process of a drug moving from its site of administration into the bloodstream. Factors such as the route of administration (e.g., oral, intravenous, etc.), formulation, and individual physiological differences can affect absorption.

2. Distribution: Once a drug is in the bloodstream, it gets distributed throughout the body to various tissues and organs. This process is influenced by factors like blood flow, protein binding, and lipid solubility of the drug.

3. Metabolism: Drugs are often chemically modified in the body, typically in the liver, through processes known as metabolism. These changes can lead to the formation of active or inactive metabolites, which may then be further distributed, excreted, or undergo additional metabolic transformations.

4. Excretion: This is the process by which drugs and their metabolites are eliminated from the body, primarily through the kidneys (urine) and the liver (bile).

Understanding the kinetics of a drug is crucial for determining its optimal dosing regimen, potential interactions with other medications or foods, and any necessary adjustments for special populations like pediatric or geriatric patients, or those with impaired renal or hepatic function.

Phosphorylation is the process of adding a phosphate group (a molecule consisting of one phosphorus atom and four oxygen atoms) to a protein or other organic molecule, which is usually done by enzymes called kinases. This post-translational modification can change the function, localization, or activity of the target molecule, playing a crucial role in various cellular processes such as signal transduction, metabolism, and regulation of gene expression. Phosphorylation is reversible, and the removal of the phosphate group is facilitated by enzymes called phosphatases.

It is an estrogen, or an agonist of the estrogen receptors, the biological target of estrogens like estradiol. EEs are a ... Esterified estrogens (EEs), sold under the brand names Estratab and Menest among others, is an estrogen medication which is ... October 2004). "Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis". JAMA. 292 (13): 1581- ... ISBN 978-0-85369-840-1. "Esterified estrogens". Kuhl H (August 2005). "Pharmacology of estrogens and progestogens: influence of ...
CEEs are estrogens, or agonists of the estrogen receptor, the biological target of estrogens like estradiol. Compared to ... CEEs are a combination of estrogens, or agonists of the estrogen receptors. The major estrogen in CEEs, sodium estrone sulfate ... An estrogen preparation very similar to CEEs but differing in source and composition is esterified estrogens. In 2020, it was ... Conjugated estrogens (CEs), or conjugated equine estrogens (CEEs), sold under the brand name Premarin among others, is an ...
This is a list of steroidal estrogens or derivatives of estradiol, estrone, and estriol. Most esters of these estrogens are not ... Articles with short description, Short description is different from Wikidata, Estrogens, Steroids, Chemistry-related lists). ...
... is considered to play a significant role in women's mental health. Sudden estrogen withdrawal, fluctuating estrogen, ... The biological importance of these minor estrogens is not entirely clear. The actions of estrogen are mediated by the estrogen ... estrogen enters passively into the cell where it binds to and activates the estrogen receptor. The estrogen:ER complex binds to ... Estrogen has been shown to upregulate the peptide hormone adropin. The effect of estrogen one the immune system is in general ...
A nonsteroidal estrogen is an estrogen with a nonsteroidal chemical structure. The most well-known example is the stilbestrol ... Nonsteroidal estrogens act as agonists of the estrogen receptors, ERα and ERβ. Stilbestrols: benzestrol, bifluranol, dienestrol ... V. Craig Jordan (2013). Estrogen Action, Selective Estrogen Receptor Modulators, and Women's Health: Progress and Promise. ... "Estrogen receptor beta selective nonsteroidal estrogens: seeking clinical indications". Expert Opin Ther Pat. 20 (4): 507-34. ...
Estrogens can also be used to suppress lactation after child birth. Synthetic estrogens, such as 17α-substituted estrogens like ... Estrogens are agonists of the estrogen receptors, the biological targets of endogenous estrogens like estradiol. They have ... Estrogens that have been marketed come in two major types, steroidal estrogens and nonsteroidal estrogens. Estradiol, estrone, ... 3. Estrogen preparations and combination preparations]" [Estrogen therapy in practice. 3. Estrogen preparations and combination ...
... is a form of estrogen that is delivered by intravaginal administration. Vaginally administered estrogens are ... Estrogen administered vaginally should not be given to persons who are: Estrogen should not be used while pregnant as it could ... To effectively alleviate the symptoms of menopause, it is best to take oral estrogen instead of topical estrogen since the ... "Estrogen (Vaginal route)". Mmddic/DDIC602127. National Center for Biotechnology Information. 2015-10-01. "Estrogen Vaginal ...
Endogenous estrogens (e.g., estradiol, estrone, estriol, estetrol) Natural estrogens (e.g., conjugated estrogens) Synthetic ... Estrogen receptors also occur within the cell nucleus, and both estrogen receptor subtypes have a DNA-binding domain and can ... Some estrogen receptors associate with the cell surface membrane and can be rapidly activated by exposure of cells to estrogen ... Estrogen insensitivity syndrome is a rare intersex condition with 5 reported cases, in which estrogen receptors do not function ...
A catechol estrogen is a steroidal estrogen that contains catechol (1,2-dihydroxybenzene) within its structure. The catechol ... 2-Hydroxylated catechol estrogens are weak and possibly antiestrogenic estrogens, whereas their 4-hydroxylated counterparts are ... The catechol estrogens are formed from estradiol and estrone by cytochrome P450 enzymes predominantly in the liver but also in ... Under poor conditions of inactivation by phase II enzymes, catechol estrogens can undergo oxidation to reactive quinones and ...
... (ED) is a theory about a metabolic state where the level of estrogen outweighs the level of progesterone in ... Estrogen dominance can affect both men and women. Estrogen dominance is widely discussed by many proponents and on many ... "Estrogen's Effects on the Female Body". Johns Hopkins Medicine. 19 November 2019. Retrieved 10 March 2022. "Estrogen & The ... contraindications to estrogen supplementation and estrogen toxicity. Research on hormone replacement therapies have indicated ...
An estrogen conjugate is a conjugate of an endogenous estrogen. They occur naturally in the body as metabolites of estrogens ... Estrogen conjugates have been used as pharmaceutical estrogens, as in estrone sulfate as estropipate (piperazine estrone ... Estrogen conjugates include sulfate and/or glucuronide conjugates of estradiol, estrone, and estriol: Sulfated: Estrone 3- ... They serve as a circulating reservoir for estrogen, particularly in the case of orally administered pharmaceutical estradiol. ...
Estrogen therapies, including the use of an estrogen patch, can be used to alleviate these symptoms by increasing estrogen ... An estrogen patch, or oestrogen patch, is a transdermal delivery system for estrogens such as estradiol and ethinylestradiol ... During menopause, the ovaries stop producing estrogen which causes estrogen levels to fall. The sudden change in estrogen ... Estrogen patches may be effective in preventing osteoporosis in postmenopausal women. Research suggests that estrogen patches ...
An estrogen ester is an ester of an estrogen, most typically of estradiol but also of other estrogens such as estrone, estriol ... estrogen esters do not bind to the estrogen receptor except at extremely high concentrations. The residual affinity of estrogen ... Estrogen esters are rapidly hydrolyzed into their parent estrogen by esterases once they have been released from the depot. ... Estrogen esters are used in hormone therapy, hormonal contraception, and high-dose estrogen therapy (e.g., for prostate cancer ...
... and esterified estrogens (Estratab, Menest). List of estrogens § Equine estrogens Kuhl H (2005). "Pharmacology of estrogens and ... Equine estrogens, or horse estrogens, are estrogens found in horses. They include the following: Estradiol Estrone Equilin (Δ7- ... Bhavnani BR (June 2003). "Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the ... Equine estrogens are found in the human medications conjugated estrogens (Premarin) ...
In the typical estrogen pathway (i) estrogen or other selective estrogen receptor modulators (SERMs) are bound to the estrogen ... There are two main types of estrogen receptors: estrogen receptor alpha (ERα) also known as NR3B1, and estrogen receptor beta ( ... The estrogen receptor test (ERT) is a laboratory test to determine whether cancer cells have estrogen receptors. This ... Growing exposure of the mammary epithelium to estrogen is related to the risk of breast cancer as the binding of estrogen to ...
Endogenous estrogens (e.g., estradiol, estrone, estriol, estetrol) Natural estrogens (e.g., conjugated estrogens) Synthetic ... "Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists". ... Luo T, Kim JK (August 2016). "The Role of Estrogen and Estrogen Receptors on Cardiomyocytes: An Overview". The Canadian Journal ... Pettersson K, Gustafsson JA (2001). "Role of estrogen receptor beta in estrogen action". Annual Review of Physiology. 63: 165- ...
Estrogen is a critical sex hormone for women (in conjunction with progesterone). Estrogen is responsible for all different ... This termination of menses is associated with a dramatic drop in estrogen levels. The estrogen levels stated previously ... Androgen-dependent condition Estrogen insensitivity syndrome "Estrogen: Hormone, Function, Levels & Imbalances". Cleveland ... An estrogen-dependent condition can be that relating to the differentiation in the steroid sex hormone that is associated with ...
... (EIS), or estrogen resistance, is a form of congenital estrogen deficiency or hypoestrogenism ... June 2001). "Congenital estrogen deficiency: in search of the estrogen role in human male reproduction". Molecular and Cellular ... the estrogen receptor alpha (ERα) - that results in an inability of estrogen to mediate its biological effects in the body. ... which are known to be elevated by estrogen, were all within normal ranges in spite of the extremely high levels of estrogen, ...
The estrogen provocation test, also known as the estrogen stimulation test or estrogen challenge test, is a diagnostic ... Estrogens that have been used in the estrogen provocation test include estradiol benzoate, estradiol valerate, ethinylestradiol ... Shaw RW, Butt WR, London DR, Marshall JC (May 1975). "The oestrogen provocation test: a method of assessing the hypothalamic- ... It involves the administration of a large amount of estrogen, resulting in estrogenic exposure similar to or greater than ...
ERRalpha+estrogen-related+receptor at the U.S. National Library of Medicine Medical Subject Headings (MeSH) estrogen+receptor- ... They are named because of sequence homology with estrogen receptors, but do not appear to bind estrogens or other tested ... Wang T, McDonald C, Petrenko NB, Leblanc M, Wang T, Giguere V, Evans RM, Patel VV, Pei L (April 2015). "Estrogen-related ... There are three human estrogen related receptors: ERRα (ESRRA) ERRβ (ESRRB) ERRγ (ESRRG) ERRs bind enhancers throughout the ...
Endogenous estrogens (e.g., estradiol, estrone, estriol, estetrol) Natural estrogens (e.g., conjugated equine estrogens) ... that is activated by the sex hormone estrogen. In humans, ERα is encoded by the gene ESR1 (EStrogen Receptor 1). The estrogen ... October 1994). "Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man". The New England Journal of ... Estrogen insensitivity syndrome is a very rare condition characterized by a defective ERα that is insensitive to estrogens. The ...
Estrogen insensitivity syndrome, a condition in which the estrogen receptor is defective and unable to respond to estrogens. ... Congenital estrogen deficiency is a congenital form of hypoestrogenism in which the body is unable to produce or use estrogens ... June 2001). "Congenital estrogen deficiency: in search of the estrogen role in human male reproduction". Mol. Cell. Endocrinol ... a condition in which aromatase is absent and androgens cannot be converted into estrogens. ...
An estrogen synthesis inhibitor is a type of drug which inhibits the enzymatic synthesis of estrogens, such as estradiol. They ... of inactive estrogen sulfates into active estrogens like estradiol Inhibitors of cholesterol synthesis can also reduce estrogen ... including estrogens 17β-Hydroxysteroid dehydrogenase inhibitors (17β-HSD inhibitors): inhibit the interconversion of estrogens ... Estrogen synthesis inhibitors have medical applications in the treatment of breast cancer, precocious puberty, gynecomastia, ...
... presents as a cyclic skin disorder, that may appear eczematous, papular, bullous, or urticarial ...
... s (mERs) are a group of receptors which bind estrogen. Unlike the estrogen receptor (ER), a nuclear ... Membrane steroid receptor Soltysik K, Czekaj P (April 2013). "Membrane estrogen receptors - is it an alternative way of ... Micevych PE, Kelly MJ (2012). "Membrane estrogen receptor regulation of hypothalamic function". Neuroendocrinology. 96 (2): 103 ... "Membrane and Nuclear Estrogen Receptor Alpha Actions: From Tissue Specificity to Medical Implications". Physiol Rev. 97 (3): ...
SERMs act by mimicking estrogen and replacing estrogen on estrogen receptors, blocking estrogen from binding and preventing ... Tamoxifen selectively blocks the effect of estrogen in breast tissue but acts as an estrogen agonist in the uterus and in bone ... Modalities include antiestrogens or estrogen blockers such as selective estrogen receptor modulators (SERMs) like tamoxifen, ... which is using estrogen and/or progesterone supplements to relieve symptoms of menopause. Estrogen feeds breast cancer cells, ...
A tissue-selective estrogen complex (TSEC) is a combination of an estrogen, such as estradiol or conjugated estrogens, and a ... v t e (Combination drugs, Estrogens, Selective estrogen receptor modulators, All stub articles, Genito-urinary system drug ... Lello S, Capozzi A, Scambia G (2017). "The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the ... It is thought to have different tissue pattern of estrogenic and antiestrogenic effects than that of either the estrogen or the ...
"Estrogen-related receptor-gamma and peroxisome proliferator-activated receptor-gamma coactivator-1alpha regulate estrogen- ... "Entrez Gene: ESRRG estrogen-related receptor gamma". Eudy JD, Yao S, Weston MD, Ma-Edmonds M, Talmadge CB, Cheng JJ, Kimberling ... Estrogen-related receptor gamma (ERR-gamma), also known as NR3B3 (nuclear receptor subfamily 3, group B, member 3), is a ... Heard DJ, Norby PL, Holloway J, Vissing H (Mar 2000). "Human ERRgamma, a third member of the estrogen receptor-related receptor ...
This is a list of estrogen esters, or ester prodrugs of estrogens. It includes esters, as well as ethers, of steroidal ... for efficient oral estrogen treatment and abolished effects on estrogen modulated liver functions". J. Steroid Biochem. Mol. ... Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy. World Health Organization. ... "Relative duration of action of natural and synthetic estrogens administered parenterally in women with estrogen deficiency". ...
A selective estrogen receptor degrader or downregulator (SERD) is a type of drug which binds to the estrogen receptor (ER) and ... "Rintodestrant , oral selective estrogen receptor degrader (SERD) , G1 Therapeutics, Inc". www.g1therapeutics.com. Retrieved ... They are used to treat estrogen receptor-sensitive or progesterone receptor-sensitive breast cancer, along with older classes ... v t e (Selective estrogen receptor degraders, Antiestrogens, Hormonal antineoplastic drugs, All stub articles, Genito-urinary ...
It is an estrogen, or an agonist of the estrogen receptors, the biological target of estrogens like estradiol. EEs are a ... Esterified estrogens (EEs), sold under the brand names Estratab and Menest among others, is an estrogen medication which is ... October 2004). "Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis". JAMA. 292 (13): 1581- ... ISBN 978-0-85369-840-1. "Esterified estrogens". Kuhl H (August 2005). "Pharmacology of estrogens and progestogens: influence of ...
... conjugated estrogens alone and conjugated estrogens/medroxyprogesterone acetate treatment groups).. Effects on bone mineral ... The women were randomly assigned to one of eight treatment groups, receiving either placebo or conjugated estrogens, with or ... Premarin for oral administration contains a mixture of conjugated estrogens obtained exclusively from natural sources. ... Premarin for oral administration contains a mixture of conjugated estrogens obtained exclusively from natural sources, ...
Estrogens. Class Summary. Used to achieve adequate estrogenization of vaginal epithelium in young women and to maintain bone ... Bone mineral density in estrogen-deficient young women. J Clin Endocrinol Metab. 2009 Jul. 94(7):2277-83. [QxMD MEDLINE Link]. ... Contains a mixture of estrogens obtained exclusively from natural sources, occurring as the sodium salts of water-soluble ... When administered orally in the recommended doses to women adequately exposed to exogenous or endogenous estrogen, they ...
Do not take estrogens if pregnant or breastfeeding. ... conjugated estrogens) are female hormones used primarily to ... Conjugated estrogens are a mixture of several different estrogens (estrogen salts) derived from natural sources and blended to ... Estrogens should not be given to pregnant women due to the risk of harm to a fetus. Estrogens are secreted in breast milk and ... Estrogen Plus Progestin Therapy. Cardiovascular Disorders and Probable Dementia. *Estrogen plus progestin therapy should not be ...
Here, learn how having low estrogen, possibly due to menopause, can lead to osteoporosis. ... Estrogen plays an important role in maintaining bone structure. ... What happens when estrogen levels are low?. Low estrogen levels ... Estrogen influences. osteocytes, as well as other cells such as osteoblasts and osteoclasts. Low estrogen levels affect how ... Estrogen plays an important role in maintaining bone structure. Low estrogen levels can lead to porous, weakened bones and ...
Estrogen and Bazedoxifene: learn about side effects, dosage, special precautions, and more on MedlinePlus ... Estrogen and bazedoxifene may harm the fetus.. *if you are taking estrogen to prevent osteoporosis, talk to your doctor about ... Before taking estrogen and bazedoxifene,. *tell your doctor and pharmacist if you are allergic to estrogen (in many hormone ... Estrogen is in a class of medications called hormones and bazedoxifene is in a class of medications called estrogen agonist- ...
ESTROGEN 1517 (estrogen) liquid. NDC Code(s): 63083-1517-1 *Packager: Professional Complementary Health Formulas ... PREMPHASE (conjugated estrogens and medroxyprogesterone acetate) kit. PREMPRO (conjugated estrogens and medroxyprogesterone ... PREMPRO (conjugated estrogens and medroxyprogesterone acetate) tablet, sugar coated. NDC Code(s): 50090-0573-0 *Packager: A-S ... PREMARIN VAGINAL (conjugated estrogens) cream. NDC Code(s): 0046-0872-04, 0046-0872-21 *Packager: Wyeth Pharmaceuticals LLC, a ...
... includes esterified estrogens and methyltestosterone description, dosage and directions. ... Physician reviewed esterified estrogens and methyltestosterone patient information - ... Esterified estrogens and methyltestosterone. Generic name: esterified estrogens and methyltestosterone [ ess-TER-ih-fied-ESS- ... What is esterified estrogens and methyltestosterone?. Esterified estrogens are female sex hormones produced by the ovaries. ...
... * Estrogen receptor transcription and transactivation: ErbB family of ... Estrogen receptor transcription and transactivation: Genetic modifiers of cancer risks conferred by BRCA1 and BRCA2 Authors: P ... Estrogen receptor transcription and transactivation: Antitumor potential of bisphosphonates Authors: JR Green ... Estrogen receptor transcription and transactivation: Novel morphoregulatory functions for the adhesion receptor Ep-CAM in the ...
Replacement Estrogens and Breast-Cancer. Jick, H., Walker, AM., Watkins, RN., Dewart, DC., Hunter, JR., Danford, A., Madsen, S ... Dinan, BJ., & Rothman, K. (1980). Replacement Estrogens and Breast-Cancer. American Journal of Epidemiology, 112(5), 586-594. ...
... Susan Ott, M.D. 8/18/09 Who should take estrogens?. There is still a lot of controversy about estrogens, ... Estrogens should be avoided in women who have had blood clots or breast cancer. In women who have a uterus, estrogen can cause ... Estrogens improve bone density as well or better than bisphosphonates, and estrogens decrease the risk of osteoporotic ... you should ask your physician if it is OK to take estrogen. *Women who take estrogen gain less weight than women who dont. ...
These xenobiotic estrogens pose an insidious risk to wildlife and humans by disrupting reproductive and developmental processes ... A number of chemical pollutants have physiological effects mimicking those of estrogen. ... Vitellogenin is an egg-yolk precursor protein produced by the liver in response to estrogens and estrogen agonists. ... A number of chemical pollutants have physiological effects mimicking those of estrogen. These xenobiotic estrogens pose an ...
She told Medscape Medical News that although she usually does not start older women on estrogen, it is still an option for some ... Cite this: No Cognitive Difference Between Early, Late Estrogen Therapy - Medscape - Oct 19, 2014. ... When we treat with estrogen, those women who complain of that seem to get better. I have never done a double-blind study, but I ... prescribe estrogen]. I would watch and see. If they say theyre better, theyre better." ...
In a study published in Frontiers in Pharmacology, scientists reported that when estrogen-deficient mice were fed CBD, a non- ... In human females, the steep decline in estrogen levels after menopause can often lead to a host of health concerns, including ... The untreated estrogen-deficient mice developed symptoms that resembled those of postmenopausal human females, such as ... CBD shows health benefits in estrogen-deficient mice that model postmenopause Rutgers study shows cannabidiol may be a possible ...
We mapped all estrogen receptor and RNA polymerase II binding sites on a genome-wide scale, identifying the authentic cis ... Combining this unique resource with gene expression data demonstrates distinct temporal mechanisms of estrogen-mediated gene ... The estrogen receptor is the master transcriptional regulator of breast cancer phenotype and the archetype of a molecular ... regulation, particularly in the case of estrogen-suppressed genes. Furthermore, this resource has allowed the identification of ...
Women with breast cancer can use vaginal estrogen tablets and creams without an increased risk for breast cancer-specific ... those receiving higher-dose vaginal estrogen therapy (HR, 0.81; P = .31), those with estrogen receptor-positive breast disease ... Vaginal estrogen therapy can effectively treat symptoms of genitourinary syndrome of menopause - symptoms that many women with ... Women with breast cancer who use vaginal estrogen therapies, such as tablets or creams, do not face an increased risk for ...
NHS medicines information on vaginal oestrogen - what its used for, side effects, dosage and who can use it. ... Vaginal oestrogen - Brand names: Vagifem, Gina, Ovestin, Vagirux Find out how vaginal oestrogen treats vaginal dryness caused ...
... for the human recombinant estrogen receptor (hrER) binding assay. ... Performance Standards for the Human Recombinant Estrogen ...
... the PT suggested I ask my doctor about a topical estrogen cream. Anybody use an estrogen cream while breastfeeding without it ... I was prescribed an estrogen cream briefly. The dose was really low - pea sized amount twice a week instead of intravaginal or ...
... , Combination Estrogen Replacement, Estrogen-Only Hormone Replacement Therapy, Activella, ... Continuous Estrogen Replacement. Continuous Estrogen Replacement Aka: Continuous Estrogen Replacement, Combination Estrogen ... Combination Pill - Estrogen and Selective Estrogen Receptor Modulator (SERM). *Duavee (Conjugated equine Estrogen + ... Medications: Estrogen-Only Hormone Replacement Therapy * Estrogen must be taken with Progesterone if Uterus is intact ( ...
This study will enable the FDA to assess the absorption of active ingredients from topically applied compounded estradiol products. Skin permeation of estradiol from EstroGel® 0.06%, an FDA-approved estradiol transdermal gel as a safe and effective product control, will be evaluated.
... Although estrogen exerts many physiological effects in both women and men, it is most well known as the female sex ... Estrogen & SCI. The SCI neuroprotective possibilities have been extensively studied by Dr. Naren Banik and colleagues at the ... A potent antioxidant, estrogen may reduce free-radical-induced oxidative stress. Given these findings and the fact that women ... Estrogen protects against this excitotoxicity-caused cell death.. 4) Edema: Fluid accumulation at the injury site creates ...
Accumulating evidence suggests that oestrogen protects against cardiovascular disease, and oestrogen receptors have been ... Kunnas and colleagues studied a dinucleotide repeat of the alpha oestrogen receptor gene in 119 Finnish men who died suddenly. ... Oestrogen receptor gene. NEW YORK, July 31 (Praxis Press) Accumulating evidence suggests that oestrogen protects against ... Accumulating evidence suggests that oestrogen protects against cardiovascular disease, and oestrogen receptors have been ...
Esterified Estrogens and Methyltestosterone Tablets) may treat, side effects, dosage, drug interactions, warnings, patient ... The risk appears to depend on both duration of treatment1 and on estrogen dose.3 In view of these findings, when estrogens are ... 2. Estrogens Should Not Be Used During Pregnancy. The use of female sex hormones, both estrogens and progestogens, during early ... There is no evidence at present that "natural" estrogens are more or less hazardous than "synthetic" estrogens at ...
The researcher says this study provides a basis for understanding how the complex pattern of estrogen receptor gene alpha ... The mechanisms that silence the estrogen receptor gene alpha, in certain breast cancer cell lines may be closer to being ... They discovered that in estrogen receptor-negative cells - which are able to silence the expression of the estrogen receptor - ... In a previous study, the researchers found that in estrogen receptor-positive and estrogen receptor-negative mammary cell lines ...
Estrogen therapy, with or without a progestogen (progesterone and progestin), has long been prescribed to treat menopausal ... They include estrogen therapy alone or estrogen in combination with a progestogen (EPT). Unopposed estrogen in patients with an ... In fact, all of the systemic hormone therapy preparations (estrogen, estrogen and progestogen and estrogen with bazedoxifene) ... What are the options for delivery of estrogen therapy?. What is the role of estrogen therapy in the treatment of the vasomotor ...
Estrogen exposure over time may increase your risk of breast cancer, especially when combined with additional exposure through ... What role does estrogen play in the human body?. Estrogen is a type of female reproductive hormone primarily produced by the ... How much estrogen increases your risk of breast cancer?. Estrogen may be prescribed at various doses based on its intended use ... in males are estrogen receptor-positive.. If you receive a diagnosis of estrogen receptor-positive breast cancer, you may need ...
... You may be trying to access this site ... Estrogens and Osteoarthritis.. ROSNER ITZHAK A. M.D.; GOLDBERG, VICTOR M. M.D.; MOSKOWITZ, ROLAND W. M.D.. Clinical ... Tamoxifen, an estrogen antagonist, reduced erosive changes in meniscectomy-induced osteoarthritis in rabbits. By contrast, ...
... is a treatment that helps replenish low estrogen levels. This therapy involves taking the hormone estrogen on a regular basis. ... Estrogen therapy is also called unopposed estrogen therapy because a second hormone (progestin) is not used along with the ... Estrogen therapy (ET) is a treatment that helps replenish low estrogen levels. This therapy involves taking the hormone ... estrogen usually is combined with progestin. This combined therapy is called estrogen and progestin therapy. ...
Eeig1 estrogen-induced osteoclastogenesis regulator 1 [Mus musculus] Eeig1 estrogen-induced osteoclastogenesis regulator 1 [Mus ... estrogen-induced osteoclastogenesis regulator 1provided by MGI. Primary source. MGI:MGI:2138935 See related. Ensembl: ... Early estrogen-induced gene 1, a novel RANK signaling component, is essential for osteoclastogenesis. Choi HK, et al. Cell Res ... early estrogen-induced gene 1 protein. Names. family with sequence similarity 102, member A. protein FAM102A. ...
  • Premarin ( conjugated estrogens ) are female hormones used primarily to treat the symptoms of menopause and states in which there is a deficiency of estrogen, for example, in women who have had their ovaries removed. (medicinenet.com)
  • Menopause is a natural process, and it causes levels of certain hormones, including estrogen , to decrease. (medicalnewstoday.com)
  • When estrogen levels drop - for example, during menopause - a person may lose bone density. (medicalnewstoday.com)
  • Estrogen and bazedoxifene tablets are used to treat hot flashes (sudden feelings of warmth, especially in the face, neck, and chest) in women who are experiencing menopause (stage of life when menstrual periods become less frequent and stop and women may experience other symptoms and body changes). (medlineplus.gov)
  • Estrogen and bazedoxifene tablets are also used to prevent osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause. (medlineplus.gov)
  • Esterified estrogens and methyltestosterone is a combination medicine used to treat symptoms of menopause such as hot flashes or night sweats. (drugs.com)
  • Estrogens can be given to women who are within 5 years of menopause, and who have a risk of developing osteoporosis. (washington.edu)
  • Estrogens should not be started in women who are more than 10 years past menopause because they might worsen heart disease, but estrogen can protect against heart disease when given right after menopause. (washington.edu)
  • In human females, the steep decline in estrogen levels after menopause can often lead to a host of health concerns, including weight gain, cardiometabolic disease, osteoporosis, gastrointestinal disorders and cognitive decline. (eurekalert.org)
  • Vaginal estrogen therapy can effectively treat symptoms of genitourinary syndrome of menopause - symptoms that many women with breast cancer experience and which may lead to endocrine therapy noncompliance. (medscape.com)
  • Find out how vaginal oestrogen treats vaginal dryness caused by menopause, and how to take it. (www.nhs.uk)
  • EEMT (esterified estrogens and methyltestosterone) is a combination of the female hormone estrogen and the male hormone testosterone used to treat moderate to severe vasomotor symptoms associated with menopause in those patients not improved by estrogens alone. (rxlist.com)
  • The body naturally produces less estrogen after menopause, when the ovaries are removed, or as a result of some other health conditions. (healthlinkbc.ca)
  • The research in this report applies such a strategy to study alternative leaflets for conjugated estrogens, synthetic female hormones used primarily to treat vasomotor symptoms during menopause or following surgical removal of the ovaries. (rand.org)
  • Newswise - Women who have gone through menopause and who have been using a vaginal form of estrogen therapy do not have a higher risk of cardiovascular disease and cancer than women who have not been using any type of estrogen. (newswise.com)
  • This study, the first to examine potential adverse health effects in users of vaginal estrogen compared with non-users, suggests that vaginal estrogen therapy is a safe treatment for genitourinary symptoms such as burning, discomfort, and pain during intercourse associated with menopause. (newswise.com)
  • They noted that sex steroid levels changed markedly during menopause, and oestrogen deficiency after menopause caused changes within the urogenital tract. (simonfoundation.org)
  • A woman's body produces less estrogen and progesterone after menopause, changes that may increase the risk for cardiovascular diseases including heart failure, according to the American Heart Association. (news-medical.net)
  • Conjugated estrogens and medroxyprogesterone is a combination medicine used to treat menopause symptoms such as hot flashes and vaginal changes, and to prevent osteoporosis (bone loss) in menopausal women. (everydayhealth.com)
  • Estrogen and skin: the effects of oestrogen, menopause, and hormone replacement therapy on the skin. (imsociety.org)
  • Declines in estrogen associated with menopause play a key role in the pathophysiology of GSM. (medscape.com)
  • Loss of estrogens at menopause is a major cause of osteoporosis and increased fracture risk . (bvsalud.org)
  • In women who have a uterus, estrogen can cause cancer of the lining of the uterus, so another female hormone called progesterone should be given to protect the uterus. (washington.edu)
  • Estrogen therapy, with or without a progestogen (progesterone and progestin), has long been prescribed to treat menopausal symptoms. (medscape.com)
  • This is because hormone replacement drugs that are high in estrogen but low in progesterone create an imbalance in the endocrine cycle. (sharedjourney.com)
  • EST Cream Contains Both Natural Estrogen and Progesterone. (heranswer.com)
  • EST Cream is a body moisture cream containing both natural estrogen and natural progesterone. (heranswer.com)
  • Each 1/4 teaspoon contains approximately 20 mg of progesterone and 1 mg natural estrogen. (heranswer.com)
  • Could these symptoms in my 1st trimester have been the progesterone stimulating the estrogen receptors, much like when you first start taking progesterone? (progesteronetherapy.com)
  • I have been reading that you can have a estrogen dominance where estrogen in low (causing depression) but progesterone is even lower. (progesteronetherapy.com)
  • I am not overweight, small breasted, so I don't think I really have high estrogen, but perhaps high estrogen in relation to Progesterone. (progesteronetherapy.com)
  • Progesterone is rising, this does stimulate oestrogen, hence the same symptoms as when using supplemental. (progesteronetherapy.com)
  • You did have enough progesterone to sustain the pregnancy, but your oestrogen to progesterone ratio was too high. (progesteronetherapy.com)
  • A typical regimen consists of an estrogen with a dosage equivalent to 25 mcg/day of transdermal estradiol (approximately 0.3 mg of conjugated equine estrogen) given unopposed (ie, no progesterone) daily for 6 months with incremental dose increases at 6-month intervals until the required maintenance dose is achieved. (medscape.com)
  • Used to prevent endometrial hyperplasia in women with a uterus who are receiving estrogen therapy. (medscape.com)
  • Estrogens also increase secretions from the cervix and growth of the inner lining of the uterus ( endometrium ). (medicinenet.com)
  • There is an increased risk of endometrial cancer in a woman with a uterus who uses unopposed estrogens. (medicinenet.com)
  • Estrogen used alone can cause cancer of the lining of the uterus (endometrial cancer). (healthlinkbc.ca)
  • For this reason, unless you have had your uterus removed, estrogen usually is combined with progestin. (healthlinkbc.ca)
  • Among women with an intact uterus, the risks of stroke, invasive breast cancer, colorectal cancer, endometrial cancer and pulmonary embolism/deep vein thrombosis were not significantly different between vaginal estrogen users and nonusers. (newswise.com)
  • Estrogen helps develop female characteristics, and is responsible for your monthly period by causing the lining of your uterus to build up before being released every 28 days or so. (simonfoundation.org)
  • So, the question was, Could postmenopausal women without a uterus safely take estrogen-only therapy for menopausal symptoms? (time.com)
  • It is an estrogen, or an agonist of the estrogen receptors, the biological target of estrogens like estradiol. (wikipedia.org)
  • NEW YORK, July 31 (Praxis Press) Accumulating evidence suggests that oestrogen protects against cardiovascular disease, and oestrogen receptors have been localized to several cell types implicated in the pathogenesis of this disease. (the-scientist.com)
  • Steroid hormones can be grouped into five groups by the receptors to which they bind: glucocorticoids, mineralocorticoids, androgens, estrogens, and progestogens. (absoluteastronomy.com)
  • Two types of estrogen receptor exist: ER, which is a member of the nuclear hormone family of intracellular receptors, and the estrogen G protein-coupled receptor GPR30 , which is a G protein-coupled. (absoluteastronomy.com)
  • The actions of estrogens on the cardiovascular system occur either indirectly through the modification of cardiovascular risk factors [reduction of plasma LDL cholesterol, elevation of HDL cholesterol, effect on hemostatic factors (reduction of fibrinogen and inhibitors of fibrinolysis)] or directly mediated by the estrogen receptors (ERs, defined as genomic action of estrogens) or other receptors. (benthamscience.com)
  • Adding a progestin to estrogen therapy has been shown to reduce the risk of endometrial hyperplasia, which may be a precursor to endometrial cancer . (medicinenet.com)
  • Breast cancer risk may increase slightly after long-term estrogen, but in the first 5 years there are more cases in women taking a placebo than in women taking estrogen without progestin. (washington.edu)
  • On the other hand, combination HRT with estrogen-progestin also increases your risk, but this may go down slightly after you stop taking it. (healthline.com)
  • Estrogen therapy is also called unopposed estrogen therapy because a second hormone (progestin) is not used along with the estrogen. (healthlinkbc.ca)
  • This combined therapy is called estrogen and progestin therapy. (healthlinkbc.ca)
  • But researchers are continually learning more about which women can safely use estrogen or progestin, and when. (time.com)
  • The study looked at the effects of both combination hormone therapy, including both estrogen and progestin, and estrogen-only treatment. (time.com)
  • That led doctors to change the way they prescribed estrogen and progestin therapy for postmenopausal women, limiting its use to short periods and only to help women manage the worst symptoms of hot flashes and night sweats. (time.com)
  • These women must take progestin along with estrogen in order to combat the increased risk of endometrial cancer - cancer of the uterine lining - caused by excess estrogen. (time.com)
  • For primary amenorrhea, hormone therapy, consisting of an estrogen and a progestin, is recommended for women with estrogen deficiency. (medscape.com)
  • Hormone therapy, consisting of an estrogen and a progestin, is needed for women in whom estrogen deficiency remains because ovarian function cannot be restored. (medscape.com)
  • Cite this: Vaginal Estrogen Therapy Safe for Women With Breast Cancer - Medscape - Nov 03, 2023. (medscape.com)
  • THURSDAY, Sept. 28, 2023 (HealthDay News) -- Being exposed to more estrogen throughout life -- or a longer reproductive life span -- may be good for the brain, according to new research that found a lower risk of cerebral small vessel disease in women who had more cumulative exposure. (msdmanuals.com)
  • Esterified estrogens are female sex hormones produced by the ovaries. (drugs.com)
  • A Rutgers study points to cannabidiol (CBD), a major component of hemp and medical marijuana used to treat conditions such as chronic pain, inflammation, migraines, epilepsy, autoimmune diseases, depression, and anxiety, as a possible treatment for postmenopausal women, whose ovaries no longer make estrogen. (eurekalert.org)
  • In women, estrogen is primarily produced by the ovaries. (healingtherapies.info)
  • Estrogen is a type of female reproductive hormone primarily produced by the ovaries, skin, and fat tissues. (healthline.com)
  • In pre-menopausal women, the most important producer of estrogens are the ovaries. (precisionnutrition.com)
  • LH and FSH stimulate secretion of estrogen from the ovaries. (precisionnutrition.com)
  • Estrogen is a female sex hormone produced by the ovaries. (everydayhealth.com)
  • Esterified estrogens (EEs), sold under the brand names Estratab and Menest among others, is an estrogen medication which is used hormone therapy for menopausal symptoms and low sex hormone levels in women, to treat breast cancer in both women and men, and to treat prostate cancer in men. (wikipedia.org)
  • 3 In view of these findings, when estrogens are used for the treatment of menopausal symptoms, the lowest dose that will control symptoms should be utilized and medication should be discontinued as soon as possible. (rxlist.com)
  • These effects appear to become most prominent during times of estrogen deficiency, such as the menopausal transition. (medscape.com)
  • ET can help reverse the effects of low estrogen, which may include severe menopausal symptoms, such as hot flashes and insomnia, and long-term problems, such as weak and brittle bones (osteoporosis). (healthlinkbc.ca)
  • Significantly lower levels of oestrogen in peri-menopausal and post-menopausal women could increase their risk of stress urinary incontinence, according to Austrian researchers. (simonfoundation.org)
  • Estrone (sometimes known as E1) is the most dominant estrogen in menopausal women. (precisionnutrition.com)
  • According to Kalenga, the study's findings suggest that if menopausal woman take hormone therapy, there are different types of estrogen that may have lower cardiovascular risks. (news-medical.net)
  • Among more than 7,600 post-menopausal women who had had a hysterectomy, 151 women in the estrogen group developed breast cancer during the trial, compared with 199 women in the control group. (time.com)
  • This preclinical study is the first to suggest the therapeutic potential of CBD for alleviating symptoms of estrogen deficiency," said Diana Roopchand , an assistant professor in the Department of Food Science of the Rutgers School of Environmental and Biological Sciences (SEBS) and senior author on the study. (eurekalert.org)
  • Many symptoms are attributed to estrogen deficiency and they vary in intensity among women. (medscape.com)
  • [ 74 ] Girls with primary amenorrhea typically do not have symptoms of estrogen deficiency. (medscape.com)
  • Estrogen deficiency and chronic alcohol consumption may have a synergistic and deleterious effect on bone tissue. (bvsalud.org)
  • Aim: To investigate the effects of estrogen deficiency associated with chronic alcohol consumption on the mandibular condyle in rats. (bvsalud.org)
  • In order of potency, naturally occurring estrogens are 17 (beta)-estradiol (E2), estrone (E1), and estriol (E3). (medscape.com)
  • Estradiol (sometimes known as E2) is the most potent estrogen. (precisionnutrition.com)
  • Most often when people talk about "estrogen" they really mean estradiol. (precisionnutrition.com)
  • Compared to estradiol, conjugated equine estrogen was associated with an 8% increased risk of developing high blood pressure. (news-medical.net)
  • In total, levonorgestrel + ethinyl estradiol and ethonogestrel + ethinyl estradiol are considered to be of the highest environmental risk, drosperinone + ethinyl estradiol of lower risk (based on the gestagen component) and nomegestrol and estradiol of the lowest risk (based on the primary gestagen component but also the estrogen component). (janusinfo.se)
  • The effects of conjugated equine estrogens (CEE) 0.625 mg daily on cytochrome P450 (CYP) were quantified in 12 middle-aged and 13 elderly postmenopausal women at baseline and 6 months later. (nih.gov)
  • and conjugated equine estrogen, an animal-derived form of estrogen and the oldest type of estrogen therapy. (news-medical.net)
  • esterified estrogens and methyltestosterone is usually given only short-term (such as 3 to 6 months). (drugs.com)
  • Esterified estrogens and methyltestosterone may also be used for purposes not listed in this medication guide. (drugs.com)
  • Esterified estrogens and methyltestosterone may cause serious side effects. (drugs.com)
  • Our EEMT (esterified estrogens and methyltestosterone) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. (rxlist.com)
  • What is Prempro (Conjugated Estrogens And Medroxyprogesterone) used for? (everydayhealth.com)
  • Do not use conjugated estrogens and medroxyprogesterone if you are pregnant. (everydayhealth.com)
  • Conjugated estrogens and medroxyprogesterone should not be used to prevent heart disease, stroke, or dementia, because this medicine may actually increase your risk of developing these conditions. (everydayhealth.com)
  • Can I take Prempro (Conjugated Estrogens And Medroxyprogesterone) if I'm pregnant or breastfeeding? (everydayhealth.com)
  • Premarin for oral administration contains a mixture of conjugated estrogens obtained exclusively from natural sources. (centerwatch.com)
  • Premarin for oral administration contains a mixture of conjugated estrogens obtained exclusively from natural sources, occurring as the sodium salts of water-soluble estrogen sulfates blended to represent the average composition of material derived from pregnant mares' urine. (centerwatch.com)
  • Does Premarin (conjugated estrogens) cause side effects? (medicinenet.com)
  • Drug interactions of Premarin include warfarin , because estrogens increase the liver 's ability to manufacture factors that promote the clotting of blood. (medicinenet.com)
  • Use of any of these medications with Premarin may result in a reduction of the beneficial effects of estrogens. (medicinenet.com)
  • What are the important side effects of Premarin (conjugated estrogens)? (medicinenet.com)
  • Taking bazedoxifene along with estrogen may decrease the risk that you will develop endometrial cancer. (medlineplus.gov)
  • Your doctor may tell you not to take estrogen and bazedoxifene if you have abnormal vaginal bleeding. (medlineplus.gov)
  • Your doctor may tell you not to take estrogen and bazedoxifene. (medlineplus.gov)
  • Your doctor may tell you to stop taking estrogen and bazedoxifene 4 to 6 weeks before the surgery or bed rest to decrease the risk that you will develop blood clots. (medlineplus.gov)
  • Estrogen and bazedoxifene should not be used to prevent heart disease, heart attacks, strokes, or dementia. (medlineplus.gov)
  • Talk to your doctor regularly about the risks of taking estrogen and bazedoxifene. (medlineplus.gov)
  • Esterified estrogens/methyltestosterone Estrogenic substances Conjugated estriol List of combined sex-hormonal preparations Sherif K (14 May 2013). (wikipedia.org)
  • In a study published in Frontiers in Pharmacology , scientists reported that when estrogen-deficient mice were fed CBD, a non-intoxicating compound extracted from hemp, they showed marked improvement in several areas. (eurekalert.org)
  • The study, published in the British Journal of Pharmacology , focused specifically on phytoestrogens, plant-based estrogen alternatives commonly found in soy, soy products, and other legumes. (medpagetoday.com)
  • The Women's Health Initiative (WHI) estrogen-alone substudy reported increased risks of stroke and deep vein thrombosis ( DVT ) in postmenopausal women (50 to 79 years of age) during 7.1 years of treatment with daily oral conjugated estrogens (CE) [0.625 mg]-alone, relative to placebo. (medicinenet.com)
  • The WHI Memory Study (WHIMS) estrogen-alone ancillary study of WHI reported an increased risk of developing probable dementia in postmenopausal women 65 years of age or older during 5.2 years of treatment with daily CE (0.625 mg)-alone, relative to placebo. (medicinenet.com)
  • Verdier-Sevrain S. Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators. (imsociety.org)
  • Estrogen plays an important role in maintaining bone structure. (medicalnewstoday.com)
  • The hormone estrogen regulates bone metabolism. (medicalnewstoday.com)
  • Low estrogen levels affect how these cells function, making them produce too little new bone and not properly maintain bone structure. (medicalnewstoday.com)
  • Scientists think that estrogen affects bone homeostasis by regulating the immune system. (medicalnewstoday.com)
  • Estrogens improve bone density as well or better than bisphosphonates, and estrogens decrease the risk of osteoporotic fractures. (washington.edu)
  • The untreated estrogen-deficient mice developed symptoms that resembled those of postmenopausal human females, such as metabolic dysfunction, evidence of inflammation, lower bone density, and lower levels of beneficial gut bacteria. (eurekalert.org)
  • In aging men, elevated estrogen levels are associated with an increased risk of stroke, heart disease, and prostate problems, and low levels with osteoporosis and bone fractures. (healingtherapies.info)
  • The same held true when covering the role of these estrogen alternatives in changes in bone mineral density. (medpagetoday.com)
  • Estrogen acts on bone to determine the overall balance of breakdown and formation. (precisionnutrition.com)
  • Estrogen inhibits bone breakdown and may stimulate bone formation by initiating synthesis of IGF-1. (precisionnutrition.com)
  • Estrogens protect against bone loss by decreasing osteoclast number through direct actions on cells of the myeloid lineage. (bvsalud.org)
  • However, we show herein that FasL-deficient mice lose bone mass following ovariectomy indistinguishably from FasL-intact controls, indicating that FasL is not a major contributor to the anti-osteoclastogenic actions of estrogens . (bvsalud.org)
  • Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. (nature.com)
  • In other words, the presence of a specific pRb2/p130 multimolecular complex may dictate a local change of the DNA structure of the estrogen receptor alpha gene and influence its susceptibility to chemical modification (DNA methylation), as well as to different epigenetic alterations leading to estrogen receptor alpha silencing," added Marcella Macaluso, research assistant professor at the Sbarro Institute and the study's lead author. (sciencedaily.com)
  • To investigate the phenotype associated with estrogen receptor alpha (ER) expression in breast carcinoma, gene expression profiles of 58 node-negative breast carcinomas discordant for ER status were determined using DNA microarray technology. (lu.se)
  • Lipitor), painkiller ibuprofen , herbal remedy Ginkgo biloba , sleep-inducing hormone melatonin , cancer-fighting quercetin found in foods, and the ubiquitous supplement vitamin E. This update specifically discusses another potential neuroprotectant with extensive human use, specifically the hormone estrogen . (healingtherapies.info)
  • This therapy involves taking the hormone estrogen on a regular basis. (healthlinkbc.ca)
  • The hormone estrogen is responsible for many important functions in the body, including breast development in women. (scienceupdate.com)
  • Women have the hormone estrogen in their bodies. (simonfoundation.org)
  • When administered orally in the recommended doses to women adequately exposed to exogenous or endogenous estrogen, they transform the proliferative endometrium into a secretory one. (medscape.com)
  • Three independent case control studies have reported an increased risk of endometrial cancer in postmenopausal women exposed to exogenous estrogens for prolonged periods. (rxlist.com)
  • Talk to your doctor from time to time to decide if you should take a lower dose of estrogen or should stop taking the medication. (medlineplus.gov)
  • According to the National Cancer Institute , estrogen-only HRT may increase your risk of breast cancer, and this risk does not decrease if you stop taking the medication. (healthline.com)
  • Epidemiology of exogenous estrogens. (cdc.gov)
  • Markush, R. E. and Turner, S. L. "Epidemiology of exogenous estrogens. (cdc.gov)
  • There are actually a few forms of estrogen - the term usually refers to a family of steroid hormones that are synthesized in a variety of tissues. (precisionnutrition.com)
  • In a large study, women who take estrogen had a higher risk of heart attacks, strokes, blood clots in the lungs or legs, breast cancer, and dementia (loss of ability to think, learn, and understand) than women who do not take estrogen. (medlineplus.gov)
  • Estrogens should be avoided in women who have had blood clots or breast cancer. (washington.edu)
  • Randomized trials and other studies have shown that women who take estrogen therapy in the form of a pill may have an increased risk of blood clots, stroke and if the estrogen is used together with progestogen pills, invasive breast cancer. (newswise.com)
  • In 2004, further data emerged: WHI researchers found that estrogen therapy increased women's risk of stroke and potentially deadly blood clots, and thus, the estrogen-only arm of the trial was also halted . (time.com)
  • The use of female sex hormones, both estrogens and progestogens, during early pregnancy may seriously damage the offspring. (rxlist.com)
  • The estrogen receptor is the master transcriptional regulator of breast cancer phenotype and the archetype of a molecular therapeutic target. (nature.com)
  • We mapped all estrogen receptor and RNA polymerase II binding sites on a genome-wide scale, identifying the authentic cis binding sites and target genes, in breast cancer cells. (nature.com)
  • Furthermore, this resource has allowed the identification of cis -regulatory sites in previously unexplored regions of the genome and the cooperating transcription factors underlying estrogen signaling in breast cancer. (nature.com)
  • Women with breast cancer who use vaginal estrogen therapies, such as tablets or creams, do not face an increased risk for breast cancer-specific mortality, which can provide some reassurance to patients and providers that vaginal estrogen therapies are safe in this population. (medscape.com)
  • It remains unclear, however, whether vaginal estrogen therapy can affect breast cancer recurrence or mortality in this patient population. (medscape.com)
  • The research team wanted to determine whether the risk for breast cancer-specific mortality was higher in women who used vaginal estrogen therapy vs those who did not use hormone replacement therapy . (medscape.com)
  • After a breast cancer diagnosis, 5% of women used vaginal estrogen therapy and 2% received systemic hormone replacement therapy. (medscape.com)
  • The mechanisms that silence the estrogen receptor gene alpha, in certain breast cancer cell lines may be closer to being unlocked, according to a new study. (sciencedaily.com)
  • The researcher says this study provides a basis for understanding how the complex pattern of estrogen receptor gene alpha methylation and transcriptional silencing is generated, as well as for understanding the relationship between this pattern and its function during breast cancer progression. (sciencedaily.com)
  • The mechanisms that silence the estrogen receptor gene alpha (ER-α) in certain breast cancer cell lines may be closer to being unlocked, according to a study by researchers at Temple University's Sbarro Institute for Cancer Research and Molecular Medicine. (sciencedaily.com)
  • In a previous study, the researchers found that in estrogen receptor-positive and estrogen receptor-negative mammary cell lines of women who have been affected with breast cancer, the tumor-suppressing gene pRb2/p130 binds to a specific region of the estrogen receptor gene alpha and forms molecular complexes recruiting and/or interacting with several proteins. (sciencedaily.com)
  • Our hypothesis is that the sequence of epigenetic events for establishing and maintaining the silenced state of the estrogen receptor gene alpha during the breast cancer progression is mediated by pRb2/p130 in association with specific proteins that modified the DNA structure through specific mechanisms," said Giordano, who discovered the Rb2 gene while working at Temple's Fels Cancer Institute in the early 1990s. (sciencedaily.com)
  • The researchers reported their findings, "Epigenetic Modulation of Estrogen Receptor-α by pRb Family Proteins: A Novel Mechanism in Breast Cancer," in the Aug. 15 issue of the journal Cancer Research (abstract 67/16/7731). (sciencedaily.com)
  • Can Estrogen Increase Your Risk of Breast Cancer? (healthline.com)
  • High amounts of estrogen or prolonged exposure throughout your life may increase your risk of breast cancer. (healthline.com)
  • However, in some cases, increased estrogen exposure over your lifetime may increase your risk of developing breast cancer. (healthline.com)
  • In this article, we take a closer look at estrogen, including when and why it may increase your risk of developing breast cancer and steps you can take to lower your risk. (healthline.com)
  • While HRT may increase your risk of breast cancer, there are other factors that can increase your estrogen exposure and subsequent cancer risk. (healthline.com)
  • What are the non-estrogen-related risk factors of breast cancer? (healthline.com)
  • Aside from estrogen exposure, other factors may increase your lifetime risk of developing breast cancer . (healthline.com)
  • The G protein-coupled estrogen receptor (GPER) mediates both the genomic and nongenomic effects of estrogen and has been implicated in breast cancer development. (jci.org)
  • Now the scientists have looked at the data again, tracking women for an additional five years after they stopped taking estrogen, and found that after 12 years of follow-up, women taking estrogen-only therapy showed a 23% lower risk of breast cancer than those who took a placebo. (time.com)
  • Among the women who developed cancer, those taking estrogen were 63% less likely to die from breast cancer than non-estrogen-users during the 12 years. (time.com)
  • It goes against a huge number of observational studies suggesting estrogen would increase the risk of breast cancer by itself. (time.com)
  • The longer you take estrogen, the greater the risk that you will develop endometrial cancer. (medlineplus.gov)
  • Do not take any other medications that contain estrogen during your treatment because this may increase the risk that you will develop endometrial cancer. (medlineplus.gov)
  • These studies are further supported by the finding that incidence rates of endometrial cancer have increased sharply since 1969 in eight different areas of the United States with population-based cancer reporting systems, an increase which may be related to the rapidly expanding use of estrogens during the last decade. (rxlist.com)
  • The three case control studies reported that the risk of endometrial cancer in estrogen users was about 4.5 to 13.9 times greater than in nonusers. (rxlist.com)
  • However, the molecular mechanisms underlying the rapid effects of estrogen on the dendritic spines of cortical neurons are not clear. (jneurosci.org)
  • These results implicate ERβ signaling in controlling dendritic spine morphology, in part via a PAK/ERK1/2-dependent pathway, and provide mechanistic insight into the rapid cellular effects of estrogen on brain function. (jneurosci.org)
  • EEs contain synthetic, plant-derived estrogens and are manufactured from soybeans and yams. (wikipedia.org)
  • There is no evidence at present that "natural" estrogens are more or less hazardous than "synthetic" estrogens at equiestrogenic doses. (rxlist.com)
  • How does estrogen affect osteoporosis? (medicalnewstoday.com)
  • Low estrogen levels can lead to porous, weakened bones and osteoporosis. (medicalnewstoday.com)
  • Below, learn how estrogen influences osteoporosis, how to prevent the condition, and what the treatments entail. (medicalnewstoday.com)
  • How does estrogen help with osteoporosis? (medicalnewstoday.com)
  • Some people use estrogen replacement therapy (ERT) to prevent or reverse osteoporosis. (medicalnewstoday.com)
  • When a person has low levels of estrogen, they have an increased risk of osteoporosis and fractures. (medicalnewstoday.com)
  • However, with inadequate estrogen exposure over time, these patients are at increased risk for developing osteoporosis and possibly other health issues. (medscape.com)
  • If you have migraine headaches, uterine fibroids, high triglycerides in your blood, lupus, chronic liver disease or endometriosis, you should ask your physician if it is OK to take estrogen. (washington.edu)
  • Women who take estrogen gain less weight than women who don't. (washington.edu)
  • The women were randomly assigned to one of eight treatment groups, receiving either placebo or conjugated estrogens, with or without medroxyprogesterone acetate. (centerwatch.com)
  • 0.001) for all treatment groups (conjugated estrogens alone and conjugated estrogens/medroxyprogesterone acetate treatment groups). (centerwatch.com)
  • Although estrogen exerts many physiological effects in both women and men, it is most well known as the female sex hormone. (healingtherapies.info)
  • Estrogen is often thought of as the "female sex hormone", but in fact it's prevalent in both men and women. (precisionnutrition.com)
  • Women taking oral estrogen therapy had a 14% higher risk of developing high blood pressure compared to those using transdermal estrogen and a 19% higher risk of developing high blood pressure compared to those using vaginal estrogen creams or suppositories. (news-medical.net)
  • In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and other dosage forms of estrogens. (medicinenet.com)
  • Although the evidence must be considered preliminary, one study suggests that cyclic administration of low doses of estrogen may carry less risk than continuous administration, it therefore appears prudent to utilize such a regimen. (rxlist.com)
  • Young women in whom secondary sex characteristics have failed to develop fully should be exposed initially to very low doses of estrogen in an attempt to mimic the gradual pubertal maturation process. (medscape.com)
  • Estrogen-alone therapy should not be used for the prevention of cardiovascular disease or dementia . (medicinenet.com)
  • Similarly inconclusive findings appeared in the case of cardiovascular health, where Rietjens and colleagues found that "the current evidence [for phytoestrogens] appears poor compared to that available for estrogens. (medpagetoday.com)
  • In this chapter, the overall actions of estrogens on the cardiovascular system and particularly on the vascular wall, as well as actions of estrogens on many different metabolic pathways affecting the cardiovascular system will be analyzed. (benthamscience.com)
  • Cardiovascular Actions of Estrogens, Women's Heart and Estrogens (2015) 1: 31. (benthamscience.com)
  • Estrogen derivatives are a key component of many oral contraceptives and have been used for postmenopausal hormone-replacement therapy. (healingtherapies.info)
  • Once the diagnosis is established, for some women with oligomenorrhea or amenorrhea who do not wish to become pregnant, oral contraceptives may be a good choice to restore menstrual cyclicity and provide estrogen replacement. (medscape.com)
  • Estrogen therapy (ET) is a treatment that helps replenish low estrogen levels. (healthlinkbc.ca)
  • He says estrogen therapy holds promise as a treatment for hearing loss in the future. (scienceupdate.com)
  • Hormone replacement therapy can also cause estrogen dominance. (sharedjourney.com)
  • Women ages 45 years and older taking estrogen hormone therapy in pill form were more likely to develop high blood pressure than those using transdermal (topical, applied to the skin) or vaginal formulations, according to new research published today in Hypertension , a peer-reviewed American Heart Association journal. (news-medical.net)
  • We chose to dive deeper into factors associated with hormone therapy, such as the route of administration (oral vs. non-oral) and type of estrogen, and how they may affect blood pressure. (news-medical.net)
  • This study involved a large group of over 112,000 women, ages 45 years and older, who filled at least two consecutive prescriptions (a six-month cycle) for estrogen-only hormone therapy, as identified from health administrative data in Alberta, Canada between 2008 and 2019. (news-medical.net)
  • First, researchers investigated the relationship between route of estrogen-only hormone therapy administration and risk of developing high blood pressure at least one year after starting the treatment. (news-medical.net)
  • For this study, the researchers reviewed medical records of individuals taking estrogen-only hormone therapy. (news-medical.net)
  • Still, the safety of estrogen-only therapy remained an open question. (time.com)
  • But that doesn't mean that estrogen therapy is safe for everyone. (time.com)
  • In the study, estrogen therapy did not reduce these women's cancer risk. (time.com)
  • Both the egg donor and the surrogate mother will undergo estrogen replacement therapy once menstruation begins. (sharedjourney.com)
  • On the basis of the findings of this short-term trial, some clinicians and women will conclude that use of vaginal estrogen which, after all, is often expensive and mired in controversies surrounding hormone therapy, should be abandoned. (medscape.com)
  • You can take steps to decrease the risk that you will develop a serious health problem while you are taking estrogen. (medlineplus.gov)
  • Breastfeeding may also slightly decrease your risk because of a smaller number of menstrual cycles over your lifetime, which decreases estrogen exposure. (healthline.com)
  • High estrogen levels in women also decrease the chances of getting pregnant because they reduce libido. (sharedjourney.com)
  • Estrogens decrease osteoclast number by attenuating mitochondria oxidative phosphorylation and ATP production in early osteoclast precursors. (bvsalud.org)
  • These findings demonstrate that estrogens decrease osteoclast number by attenuating respiration , and thereby, promoting mitochondrial apoptotic death of early osteoclast progenitors. (bvsalud.org)
  • She told Medscape Medical News that although she usually does not start older women on estrogen, it is still an option for some who are still having hot flashes. (medscape.com)
  • Conversely, drugs such as erythromycin , ketoconazole , itraconazole , and ritonavir may reduce the elimination of estrogens by the liver and lead to increased levels of estrogens in the blood. (medicinenet.com)
  • Vitellogenin is an egg-yolk precursor protein produced by the liver in response to estrogens and estrogen agonists. (astm.org)
  • We know estrogens ingested orally are metabolized through the liver, and this is associated with an increase in factors that can lead to higher blood pressure. (news-medical.net)
  • Parenteral estrogen (transdermal or vaginal) is the preferred route of administration because it avoids first-pass liver metabolism. (medscape.com)
  • This avoids the first-pass effect of oral estrogen on the liver. (medscape.com)
  • Estrogens should not be given to pregnant women due to the risk of harm to a fetus. (medicinenet.com)
  • Estrogens may increase your risk of developing a condition that may lead to uterine cancer . (drugs.com)
  • These xenobiotic estrogens pose an insidious risk to wildlife and humans by disrupting reproductive and developmental processes, thereby impairing both the exposed individuals and their offspring. (astm.org)
  • The risk appears to depend on both duration of treatment 1 and on estrogen dose. (rxlist.com)
  • It has been shown that females exposed in utero to diethylstilbestrol, a non-steroidal estrogen, have an increased risk of developing in later life a form of vaginal or cervical cancer that is ordinarily extremely rare. (rxlist.com)
  • Similarly, regular exercise can help maintain a healthy weight, reducing the risk of estrogen dominance. (sharedjourney.com)
  • Additionally, researchers evaluated the formulation of estrogen used and the risk of developing high blood pressure. (news-medical.net)
  • Taking estrogen for a longer period of time or taking a higher dose was associated with greater risk of high blood pressure, the authors noted. (news-medical.net)
  • Estrogen After Hysterectomy Lowers Cancer Risk? (time.com)
  • Conjugated estrogens are a mixture of several different estrogens (estrogen salts) derived from natural sources and blended to approximate the composition of estrogens in the urine of pregnant horses. (medicinenet.com)
  • Conjugated estrogens are a mixture of estrogen hormones. (everydayhealth.com)
  • Vitellogenin induction bioassays can be used to screen chemicals for estrogenic and antiestrogenic activity, to test water for the presence of xenobiotic estrogens, and to screen wildlife populations for exposure to environmental estrogens. (astm.org)
  • Exposure to xenoestrogens is also a major cause of estrogen dominance. (sharedjourney.com)
  • Exposure to xenoestrogens can lead to anovulation (lack of ovulation), which also contributes to high estrogen levels. (sharedjourney.com)
  • because of increased exposure to estrogen, girls are beginning to develop secondary sex characteristics (pubic hair and breasts) at a younger age. (sharedjourney.com)
  • Minimizing exposure to pesticides, pollutants and plastics reduces estrogen levels. (sharedjourney.com)
  • Estrogens have widespread effects on many tissues in the body. (medicinenet.com)
  • This is because fat tissues store and release estrogen, which can increase overall estrogen levels. (healthline.com)
  • Xenobiotic estrogens are impacting both wildlife and human health, thus it is important to screen chemicals for estrogenic potential, and to monitor environmental levels of estrogenic pollutants. (astm.org)
  • Grapefruit juice also may increase levels of estrogen by increasing the absorption of estrogens from the intestine. (medicinenet.com)
  • As people age, their levels of estrogen and sema3A deplete, which leaves the bones unable to maintain their structure. (medicalnewstoday.com)

No images available that match "estrogens"